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 Zusammenfassung 
Infektionskrankheiten sind vor allem in Entwicklungsländern eine große Bedrohung 
des menschlichen Lebens. Immerhin sind 10 % aller krankheitsbedingten Tode 
weltweit auf sie zurückzuführen. Verursacht werden diese Krankheiten durch 
Bakterien, wie zum Beispiel Salmonella enterica, Shigella flexneri oder 
enteropathogene und enterohämorragische Escherichia coli, die meist auf dem 
fäkal-oralem Weg in den Organismus gelangen. Im Darm heften sich die Bakterien 
an Epithelzellen oder dringen in diese ein und beginnen sich zu vermehren. Ein 
typisches Symptom einer solchen Infektion ist schwere Diarrhö. Es ist die Aufgabe 
der Wissenschaft, die komplexen Mechanismen hinter der Wirt-Pathogen Interaktion 
zu entschlüsseln, um Infektionen begegnen zu können. 
Damit Bakterien eine Infektion etablieren können, müssen sie den 
Verteidigungsmechanismen des Wirtes entkommen. In der Regel wird dies dadurch 
erreicht, dass die Bakterien Signalwege der Wirtszelle manipulieren und sich so eine 
spezielle Nische schaffen, in der sie überleben können. Die Manipulation wird oft 
mit Hilfe eines Sekretionssystems erreicht, das es den Bakterien erlaubt 
Virulenzfaktoren in das Zytoplasma der Wirtszelle einzubringen. Hier interagieren 
die bakteriellen Proteine dann mit ihren wirtseigenen Zielen, wie beispielsweise den 
kleinen Rho GTPasen und rufen so unter anderem Veränderungen am 
Aktin-Zytokelett der Zelle hervor. 
Obwohl die Zahl der verschiedenen Effektorproteine im Reich der Bakterien groß ist, 
lassen sie sich doch auf Grund bestimmter Charakteristika in einzelne Gruppen 
einordnen. Eine besondere Gruppe unter den Virulenzfaktoren stellt die sogenannte 
WxxxE Familie dar. Zu ihren Mitgliedern gehören IpgB1 und IpgB2 (S.flexneri), 
SifA und SifB (S.enterica) sowie Map und EspT (EPEC). Sie alle teilen ein 
konserviertes WxxxE Motiv und die meisten besitzen GEF Aktivität, die es ihnen 
ermöglicht Rho GTPasen zu aktivieren. Die WxxxE Familie ist zurzeit Gegenstand 
intensiver Forschung. Durch ihre Interaktion mit Rho GTPasen erhalten Bakterien 
Zugriff auf eine Vielzahl zelluläre Prozesse, allen voran Aktin-Zytokelett 
Organisation und Vesikel Transport. Aktuelle Untersuchungen deuten jedoch darauf 
hin, dass diese bakteriellen Virulenzfaktoren noch weiter Interaktionspartner unter 
den Wirtsproteinen haben müssen, um den Bakterien die Generierung eines 
optimalen Lebensraums zu ermöglichen.  
 Das finale Ziel dieser Arbeit war es daher, weitere Interaktionen zwischen Wirts- und 
bakteriellen Proteinen aufzudecken, die möglicherweise die Komplexität von 
Wirt-Pathogen Interaktionen erklären. 
Mit Hilfe von biochemischen Methoden wie pull down assays und 
Co-Immunpräzipitationen, sowie mittels mikroskopischer Verfahren konnten 
deutliche Hinweise auf eine Interaktion zwischen dem humanen, mit RhoA 
interagierendem Protein Rhophilin1 (RHPN1) und dem Virulenzfaktor Map aus 
EPEC, der GEF Aktivität gegenüber Cdc42 besitzt, gefunden werden. In diesem 
Zusammenhang zeigen wir auch, dass RHPN1 mit der kleinen GTPase Rac1, 
zusätzlich zu RhoA, interagieren kann. Des Weiteren zeigen wir hier, dass RHPN1 
zumindest teilweise an Mitochondrien lokalisiert und stellen erst Hinweise zur 
Verfügung, die darauf hindeuten, dass RHPN1 in der Lage ist Autophagie von 
membranassoziierten EPEC in Infektionsversuchen zu induzieren.  
In parallelen Ansätzen zeigen wir, dass der bakterielle Virulenzfaktor IpgB2 aus 
S.flexneri in der Lage ist, mit dem Bardet-Biedl Syndrom Protein 4 (BBS4) in 
Interaktion zu treten. Schlussendlich scheint der S.enterica Effektor SifA mit der kleinen 
GTPase Rab9 interagieren zu können. Diese beiden ersten Erkenntnisse sind nun 
Gegenstand eigenständiger Projekte.  
Zusammengefasst unterstreicht diese Arbeit, dass das Funktionsspektrum der 
untersuchten Virulenzfaktoren weit über die einfache Aktivierung von GTPasen 
hinausgeht. Die Fähigkeit mit weiteren Wirtsproteinen interagieren zu können, 
ermöglicht letztlich die Etablierung von bakteriellen Infektionen beziehungsweise 
verdeutlicht die Verteidigungsmechanismen der Zelle. Der spannende 
Zusammenhang zwischen EPEC Infektion und Autophagie wird zurzeit weiter 
verfolgt, um unser Verständnis des komplexen Zusammenspiels von Wirtszelle und 
diesem bedeutendem Pathogen auszubauen. 
 
  
 Summary 
Infectious diseases are a serious threat of human life, especially in developing 
countries. They cause at least 10 % of all death on diseases worldwide. Bacteria like 
Salmonella enterica, Shigella flexneri, or enteropathogenic and enterohemorrhagic 
Escherichia coli cause such diseases. Usually they enter the host organism via the 
fecal-oral route.  In the intestine they attach to, or invade epithelia cells and begin to 
reproduce. Severe diarrhea is a typical symptom of those infections. In order to fight 
infections, it is the task of science to decrypt the complex mechanisms of host 
pathogen interaction. 
Prior to establishment of an infection, bacteria have to overcome the defense system 
of the host. Commonly, bacteria can accomplish this by manipulating the host´s 
signaling pathways, leading to the formation of a replication niche where the bacteria 
can survive. Often bacteria utilize a secretion system to inject virulence factors into 
the host cell cytoplasm, which in turn start manipulation of the host targets. Common 
targets are small GTPases that control rearrangements of the actin cytoskeleton.  
Although the number of different effector proteins among the bacteria is huge, it is 
possible to group them on the basis of certain characteristics. A special group of 
virulence factors is the so called WxxxE family. IpgB1 and IpgB2 (S.flexneri), SifA 
and SifB (S.enterica), as well as Map and EspT (EPEC) are family members. All of 
them contain a conserved WxxxE motive, and the majority of them embodies 
bacterial GEFs, which are able to activate Rho GTPases. Currently, the WxxxE 
family is subject of extensive research. By targeting Rho GTPases, bacteria gain 
access to a variety of cellular processes, like actin cytoskeleton organization or 
vesicle transport. Current research indicated that these bacterial virulence factors 
must have additional interactors among the host´s proteins to allow bacteria the 
generation of an optimal environment.  
The ultimate goal of this work was to identify further interactions between host- and 
bacterial proteins that may explain the complexity of host pathogen interaction. 
By using biochemical methods like pull down assays and co-immunoprecipitations 
as well as microscopic techniques we reveal evidence for an interaction between the 
human RhoA interactor rhophilin1 (RHPN1) and the virulence factor Map from 
EPEC, which embodies a bacterial GEF for Cdc42. Within this framework we also 
show that RHPN1 is able to bind, to the small GTPase Rac1 in addition to RhoA. 
Furthermore we here show an at least partial localization of RHPN1 to mitochondria 
 and provide initial evidence for RHPN1 being able to induce autophagy of EPEC 
attached to the plasma membrane by using infection assays. 
In a parallel effort, we show that the bacterial virulence factor IpgB2 from S.flexneri 
is able to get in contact with the Bardet-Biedl Syndrom Protein 4 (BBS4). Finally, 
the S.enterica effector protein SifA targets the small GTPase Rab9. These two initial 
findings are now subjects of independent projects. 
In conclusion, this work underpins once more that the spectrum of functions of the 
analyzed virulence factors goes far beyond the simple activation of GTPases. The 
ability to interact with further host proteins finally allows establishment of an 
infection or reflects cell defense mechanisms. The exiting link between EPEC 
infection and autophagy is currently followed to further our understanding of the 
complex interplay of host cells with this important pathogen.   
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®  registered trademark symbol 
%  percent 
°C  degree Celsius 
2D  two dimensional 
α  anti 
Å  ångström  
A  ampere  
aa  amino acid(s)   
A/E  attaching and effacing  
AIDS  acquired immunodeficiency syndrome 
amp  ampicillin  
ADP  adenosine diphosphate 
APS  ammoniumperoxodisulfat 
ATP  adenosine triphosphate 
BBS  Bardet-Biedl syndrome 
BSA  Bovine serum albumin 
c  centi- 
CA  constitutive active 
cDNA  complementary DNA 
CDRs  circular dorsal ruffles  
cfu  colony forming unit 
Da  Dalton 
dd  double distilled 
DKFZ  German Cancer Research Center 
DMEM Dulbeccos' modified Eagle medium 
DMSO dimethyl sulfoxide 
DN  dominant negative 
DNA  deoxyribonucleic acid 
E  glutamic acid 
EDTA  ethylenediaminetetraacetic acid 
e.g.  exempli gratia 
EHEC  enterohemorrhagic E.coli 
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EPEC  enteropathogenic E.coli 
EtOH  ethanol 
ESCRT endosomal sorting complexes required for transport 
et al.  et alii 
F-actin  filamentous actin 
FCS  fetal calf serum 
g  gram 
G  glycine 
G-actin globular actin 
GAP  GTPase activating protein 
GBD  global burden of disease 
GDI  guanosine nucleotide dissociation inhibitors 
GDP  guanosine diphosphate 
GEF  guanosine nucleotide exchange factor 
GFP  green fluorescent protein 
GST  glutathione sepharose 
GTP  guanosine triphosphate 
h  hour(s) 
HGF  hepatocyte growth factor 
HIV  human immunodeficiency virus 
HRP  horseradish peroxidase 
Hs  Homo sapience  
IF  immunofluorescence microscopy  
IFN  Interferon 
IFT  intraflagellar transport 
Ig  immunglobulin, immunglobulin-domain 
Il  interleukin  
IP  immunoprecipitation 
IPTG  isopropyl β-D-1-thiogalactopyranosid 
k  kilo- 
kana  kanamycin 
KO  knockout 
l  liter(s)  
L  leucine 
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LB  Luria Bertani broth 
LEE  locus of enterocyte effacement 
LPS  lipopolysaccharide 
m  milli- or meter(s) 
M  molar mass 
mc  monoclonal 
MBP  maltose binding protein 
MEFs  mouse embryonic fibroblast 
MEM  minimum Essential Medium Eagle 
MHC  major histocompatibility complex 
min  minute(s) 
Mm  Mus musculus 
MVB  multivesicular body 
n  nano- 
N   Newton or asparagine 
No.  number 
NPF  nucleation promoting factors 
n.s.  not significant 
OD600  optical density at 600 nm 
p  pico- 
PAGE  polyacrylamide gel electrophoresis 
PBS  phosphate buffered saline 
pc  polyclonal 
PCR  polymerase chain reaction 
PDGF  platelet-derived growth factor 
PDZ  PSD-95/Disk-large/ZO-1 binding motif 
PFA  paraformaldehyde 
Pi  phosphate 
PS  penicillin/streptomycin  
PVDF  polyvinylidenfluorid 
Q  glutamine 
RHPN  rhophilin 
rpm  rounds per minute 
s  second(s) 
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SAP  supernatant after pull down 
SCV  Salmonella containing vacuole  
SDS  sodium dodecyl sulfate 
Sifs  Salmonella induced filaments 
SN  supernatant 
SS  super-sonication 
t  time 
T  threonine 
T3SS  type 3 secretion system 
TAE  tris base, acetic acid and EDTA containing buffer 
TBS  tris-buffered saline 
TBS/T  tris-buffered saline / Tween 20 
TIF  tagged image file format 
Tir  translocated intimin receptor 
TLR  Toll like receptors 
µ  micro-  
U  unit 
V   volt or valine 
v/v  volume per volume 
W  tryptophan 
w/v  weight per volume  
WHO  world health organization 
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Figure 1 Global and regional ranking of leading causes of years of life lost (YLL) 
To calculate the YLL the years, lost by early death, till anticipated average life, in certain region or 
country are counted. With other words this graphic shows which disease “steel” how many years, 
global and in different regions. Rank one to three ischaemic heart diseases, lower respiratory 
infections and cerebeovascular diseases respectively have an equally huge influence all over the 
world, without noticeable effects of income. In other cases it is different, diarrhea for example is 
concentrated on poor regions and the influence of malaria depends on the distribution of the 
anopheles mosquito (Lozano et al., 2012).   
 
1 Introduction 
1.1 Host pathogen interaction 
Why should we study host pathogen interactions? To answer this question, a simple 
look into the latest world health organization (WHO) report on “The Global Burdon 
of Diseases” (GBD) is sufficient. In 2010 5.3 million or 76 of 100,000 people died 
on infectious diseases, these are 10 % of all death on diseases. If we take a closer 
look at diarrhea, caused for example by enteropathogenic E.coli (EPEC), Salmonella 
or Shigella, which are subject of this thesis, it becomes even more obvious. Diarrhea 
killed 1.4 million people in 2010, this is the same case number as for HIV/AIDS. 
Diarrhea is on position four of the global years of life lost (YLLs) ranking, with huge 
differences between high and low income countries (Figure 1). Every year, 1.25 
million (20 % of all death) children under an age of 5 years die of infectious diseases. 
However, one promising fact from this report is, that in the last twenty years, the 
number of deaths caused by infectious diseases decreased from 7.8 million in 1990 
by 32 %, reflecting the increased efficiency of treatment and technology of this 
poverty connected disorders (Lozano et al., 2012). 
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1.2 The Host 
1.2.1 Motion 
Motion is an essential feature of life. Cellular motility is tightly connected to the 
formation of actin driven membrane protrusions, namely lamellipodia, filopodia and 
ruffles (Small et al., 2002). In 1980 Abercrombie first linked the thin layer of 
protruding cytoplasm at the cell periphery to motility. Protrusions, parallel to the 
substrate, were named “leading edge” or “lamellipodium” (Abercrombie et al., 
1970a). Abercrombie further noticed a random continuous protrusion and retraction 
of the lamellipodium, with a net plus on protrusions, pushing the cell forward. In the 
following thirty years intensive research generated much insight to cell movements, 
so that today, the events at the leading cell edge are quite well described. The 
mechanism behind protrusion and retraction of the dynamic structures at the cell 
front is the assembly and disassembly filamentous actin (F-actin) (see 1.2.1.5). This 
process is tightly regulated in mammalian cells. Key regulators in this process are the 
small guanosine triphosphatases (GTPases) of the Rho-family (Hall, 1998). Some 
pathogens are able to hijack these cellular processes in order to manipulate the hosts 
actin cytoskeleton resulting in local ruffle formation and lamellipodia extension 
which trigger the internalization of bacteria into membrane bound vacuoles (Patel et 
al., 2005, McGhie et al., 2009). In the following passages I attempt to shed light on 
the different protrusive structures and the established factors involved in their 
regulation. Furthermore I would like to focus on actin polymerization, the core 
process behind migration.  
 
1.2.1.1 Lamellipodia and ruffles 
There is a lot of knowledge available on the lamellipodium since it has been studied 
for more than a half decade. Ingram and Abercrombie were among the first who used 
light microscopy techniques, to systematically analyze the “leading edge” of moving 
cells (Ingram, 1969, Abercrombie et al., 1970a, Ladwein et al., 2008).  
The 0.1-0.2 µm thick and 1-5 µm wide seam (according to the cell type) at the 
leading edge of the cell consists of a dense meshwork of actin-filaments, pushing 
their fast growing ends against the plasma membrane (Small et al., 1978) (Figure 2). 
If the lamellipodium detaches from the substrate and curls upwards, we have a 
special form, called “membrane ruffle” or only ruffles (Abercrombie et al., 1970b). 
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By the injection of fluorescent actin into fibroblasts, it could be shown that the 
leading edge of the lamellipodium is in fact the primary site of actin incorporation 
(Glacy, 1983). Embedded in the lamellipodium actin bundles could often be 
observed. If these bundles stay inside the lamellipodium they are called 
“microspikes” and if they extend beyond its edge they are referred to as “filopodia” 
(Small et al., 2002). Apart from their functions in cellular migration, lamellipodia 
fulfill several other important functions. Namely they participate in development of 
adhesions and are involved (as ruffles) in macropinocytosis as well as in 
phagocytosis. The exertion of those different functions demand an exact regulation. 
This regulation mainly occurs by actin polymerization and disassembly. The primary 
pathway leading to lamellipodia and ruffle formation is via the small Rho GTPase 
Rac and the actin nucleator Arp2/3 (see 1.2.1.5). The significance of GTPases for the 
actin cytoskeleton in general and of Rac for the lamellipodium in particular is known 
since Ridley and colleagues microinjected purified constitutively active Rac into 
fibroblasts and observed massive lamellipodia and ruffle formation (Ridley et al., 
1992).  
In mice the absence of Rac1 is embryonic lethal at day 6.5, because of incomplete 
gastrulation (Sugihara et al., 1998). Therefore further genetic analysis requires the 
creation of conditional alleles. This allows embryonic survival followed by tissue 
specific knockout later in differentiation (Gu et al., 2003). Using this method, Vidali 
and colleagues generated mouse embryonic fibroblasts (MEFs) deleted for Rac1. 
These cells show a dramatic change in morphology and lack lamellipodia and ruffles. 
However, their knockout (KO) cells were still able to migrate with help of 
pseudopodia like protrusions, along a platelet-derived growth factor (PDGF) gradient 
(Vidali et al., 2006).  
Introduction 4 
 
 
 
Besides membrane ruffles at the leading edge of the cell, which were already 
mentioned, there is a second type of ruffles, the so called circular dorsal ruffles 
(CDRs) (Figure 2). This highly dynamic structure is rich in F-actin. They can be 
observed a few minutes after treatment with growth factors such as PDGF 
(Mellström et al., 1983) or hepatocyte growth factor (HGF) (Dowrick et al., 1993). 
Figure 2 Schematic illustration of protrusive structures at the cell surface 
The image illustrates the protrusive membrane structures of a migrating cell. The intensity of the red 
color symbolizes the grade of actin dynamics. Finally there are four close-ups, which show the 
different structures in a higher resolution. We have lamellipodia along the leading edge with 
embedded microspikes. If the membrane curls up, either at the cell periphery or on top of the cell as 
circular structures, so called ruffles are formed. Furthermore there are rods of parallel actin, 
protruding beyond the cell borders into the extracellular space, which are termed filopodia (Ladwein 
et al., 2008). 
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The lamellipodium often curls up from the substratum and moves, like small sails, on 
the cell surface towards the cell center. Alternatively, CDRs can establish directly on 
the back of the cell in 2D tissue culture. Single membrane ruffles can group together 
and build circular ruffles, which constrict and close within 5-20 minutes (Mellström 
et al., 1983). The cup-like structure formed by CDRs goes perfectly with the process 
termed macropinocytosis and may serve receptor internalization (Swanson, 2008, 
Hoon et al., 2012). However, the impact of CDRs on macropinocytosis is under 
discussion. As Suetsugu et al. showed, the uptake of fluorescently labeled dextran 
through macropinocytosis did not occur at places of CDRs (Suetsugu et al., 2003). 
Further research will be necessary to clarify this point. 
 
1.2.1.2 Filopodia and Microspikes 
In contrast to the dense meshwork of differently angled actin filaments building the 
lamellipodium (Köstler et al., 2008), filopodia are finger like protrusive structures, 
regularly embedded in or extending beyond the lamellipodium that contain parallel 
bundles of actin filaments (Ridley, 2011). Bundles of actin which remain within the 
lamellipodium and do not protrude further are called microspikes (Small et al., 
2002). Microspikes also can serve as precursors of filopodia (Svitkina et al., 2003). 
Filopodia participate in many processes, ranging from sensing the environment 
(Wood et al., 2002b) or chemoattractants (Koleske, 2003), over anchorage of the cell 
to the extracellular substrate (Wehrle-Haller, 2012, Partridge et al., 2006), to wound 
healing (Wood et al., 2002a). Furthermore, as already mentioned in the previous 
paragraph, filopodia can develop independent of lamellipodia and take part in 
cellular motility, as it was shown e.g. in Rac1 KO cells (Vidali et al., 2006) or cells 
deficient in WAVE complex function (Steffen et al., 2006).  
Studies in different cell types revealed that there is huge variation in dynamics and 
length of filopodia, even positioning of these protrusions differ (Mattila et al., 2008). 
The dynamics of filopodia, protrusion and retraction results from the balance 
between actin polymerization at the tip and retrograde flow (Mallavarapu et al., 
1999).   
Like already described above for lamellipodia, the formation of filopodia is regulated 
by a member of small Rho GTPase family. In 1995 Hall and others investigated the 
role of small Rho GTPases by microinjection experiments combined with live time 
imaging. Co-microinjection of dominant negative Rac1, to abolish lamellipodia and 
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constitutive active Cdc42 showed, that the formation of filopodia starts after five 
minutes (Nobes et al., 1995, Kozma et al., 1995). The regulation of filopodia 
formation by Cdc42 was initially believed to occur via activation of WASP and 
N-WASP, leading subsequently to induction of the actin nucleator Arp2/3 (Prehoda 
et al., 2000, Rohatgi et al., 1999). But more recent studies have shown that filopodia 
can form independent of Arp2/3 and Cdc42 (Steffen et al., 2006, Sigal et al., 2007) 
and highlighted the role of formins and VASP (Figure 6) as actin nucleator leading to 
filopodia formation (Faix et al., 2009). Nevertheless, contribution of Arp2/3 is still 
subject of discussion (Rottner et al., 2011, Mattila et al., 2008, Yang et al., 2011). 
To concentrate single actin filaments to a stiff actin bundle, so called actin 
cross-linking proteins are necessary. One member of this group, which localizes to 
filopodia shafts is fascin, other proteins like fimbrin, α-actinin, espin and villin can 
cross-link F-actin too, but are not specifically targeted to filopodia (Kureishy et al., 
2002, Vignjevic et al., 2006). 
 
1.2.1.3 Stress fibers  
The last of the prominent cytoskeletal actin structures are stress fibers, thick bundles 
of actin filaments which pervade the cell. Each bundle consists of 10-30, in some 
cases of up to 300 filaments which are themselves composed of actin and non-muscle 
motor protein myosin II (Cramer et al., 1997, Weber et al., 1974). Bundling is 
accomplished by α-actinin, maybe in cooperation with other actin cross-linking 
proteins (Lazarides et al., 1975, Pellegrin et al., 2007). Due to their subcellular 
localization, stress fibers are grouped into three different classes, ventral and dorsal 
stress fibers plus transverse arcs (Small et al., 1998) (Figure 3). One of the first 
descriptions of those structures, although not specially named yet, was made by 
Heath and colleagues (Heath et al., 1978). The most commonly observed are ventral 
stress fibers which span the cytoplasm along the ventral side of the cell and are 
linked to focal adhesions at both ends. In contrast, dorsal stress fibers are significant 
shorter and only attached to adhesions on one side. Finally transverse arcs are 
situated at the dorsal surface, behind the lamella, and seem not to be connected to 
any adhesions (Heath et al., 1978). When the loose ends of dorsal stress fibers, or 
arcs, meet they are able to fuse, resulting in a new ventral stress fiber, so dorsal fibers 
could be seen as precursors of ventral ones (Hotulainen et al., 2006). The 
combination of focal adhesions, actin fibers and myosin II suits perfectly to generate 
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tension. The result of force measurements revealed, that a constant stress of 
5.5 ± 2 nN/µm
–2
 is applied on single adhesions by actomyosin (Balaban et al., 2001). 
Loss of stress fibers in response to C3 toxin treatment suggested participation of the 
three Rho members of the small GTPase family in the signalling pathway leading to 
stress fiber formation (Chardin et al., 1989). The role of RhoA, RhoB and RhoC, all 
main targets of C3 toxin, was validated by microinjection, which results in massive 
stress fiber formation and alters the complete cell shape (Paterson et al., 1990). 
Under physiological conditions RhoA seems to be the major regulator of stress fiber 
formation, while RhoB and RhoC fulfill a minor role or they are specialists for 
 
Figure 3 Three types of stress fibers in the cell 
In the immunofluorescence image (A) a U2OS human osteosarcoma cell stained for focal adhesions 
(red) F-actin (green) and the nucleus (blue) is shown. Ventral stress fibers, connecting two adhesions 
are located in the back part of the cell. Dorsal ones grow from focal contacts at the protruding front. 
The more filigree arcs could be found right behind the lamella. An overview of the different 
structures is given in the drawing. In (B) the periodical composition of stress fibers is illustrated by 
α-actinin (green) and F-actin (red) staining in Swiss 3T3 cells. (Bars: left 25µm; right 10µm) 
(Burridge et al., 2013). 
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particular situations or cell types (Pellegrin et al., 2007). Later two main players 
downstream of RhoA were discovered, namely the ROCK/ROK protein kinases 
(Leung et al., 1995) and the diaphanous-related formin, mDia1 (Watanabe et al., 
1997). On their own, both proteins are not able to emulate the effect of a RhoA 
overexpression. Only if ROCK and mDia1 work concurrently, they are able to 
induce thick and long actin bundles (Watanabe et al., 1999). 
 
1.2.1.4  Small GTPases 
It has already become clear in the previous chapter that dealt with protrusive 
structures, that small GTP-binding proteins have a central role in controlling cellular 
locomotion. Beyond this, they are key regulators in a lot of cellular processes, 
including cell polarity, vesicle trafficking and cytokinesis (Heasman et al., 2008). 
The story of their discovery started in 1982 with the identification of the mutationally 
activated oncogene RAS in human cancer cell lines. In the following decades 
immense effort has been put into research and a huge superfamily of Ras related 
small GTPases, which is highly conserved from yeast to mammals, has been 
discovered (Cox et al., 2010). One member is the Rho GTPase family, which 
comprise 20 proteins at the moment (Heasman et al., 2008). Among them are Cdc42, 
Rac1 and RhoA (Figure 4).  
 
 
Figure 4 Dendrogram of the small Rho GTPase family 
Members of the human Rho GTPases, shown in a Clustal/W dendrogram (Cox et al., 2010) 
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Most GTPases shuttle between two conformational stages (Figure 5), one is the GTP 
bound active stage, in which the GTPase is able to interact with its downstream 
effectors, the other is GDP bound and inactive. The dissociation of GDP and 
incorporation of GTP is catalyzed by one of over 80 guanine nucleotide exchange 
factors (GEF). This takes place at the cell membrane, to which the GTPases are 
associated via an isoprenyl moiety that is post-translationally added to the carboxyl 
terminus of the protein. The other way round, the hydrolysis of GTP is driven by 
GTPase activating proteins (GAP), there are more than twenty of them. There is one 
more regulatory component, the GDIs (guanine dissociation inhibitors), which keep 
the GTPase inactive (Aktories, 2011, Cherfils et al., 2013) and protect them from 
degradation (Boulter et al., 2010). 
 
The tight regulation of GTPases by different GEFs, GAPs and GDIs with partially 
overlapping activities has the advantage that the cell can respond specifically to 
different signals, guiding them precisely in their target pathways. This level of 
regulation is a main target of the manipulation by pathogens that have evolved 
intricate strategies to hijack or block the GTPase activation cycle. On the other side 
the cycle is prone to interference and manipulation by pathogens. In the following I 
Figure 5 Regulation of the Rho-family GTPase cycle 
The activation of Rho-family GTPases is catalyzed by GEFs and takes place at the plasma membrane. 
In the GTP bound active state, the GTPase is able to interact with its specific effector proteins to 
affect downstream pathways. GAPs enhance the intrinsic GTPase activity and thereby help to 
hydrolyze GTP to GDP+Pi. By capping the isoprenyl moiety, GDIs keep the GTPase away from the 
plasma membrane, resulting in a durable inactivation (Aktories, 2011). 
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will give several examples, to illustrate the variety of possibilities for pathogens, to 
subvert the GTPase cycle: 1) the two virulence factors of Salmonella Typhimurium, 
SpoE and SopE2, which serves as bacterial GEF for Rac1 and Cdc42 (Hardt et al., 
1998); 2) DrrA from Legionella pneumophila, which functions in two ways, by 
stimulating the GTP incorporation and by releasing its target GTPase from GDIs 
(Murata et al., 2006, Schoebel et al., 2009); 3) S. Typhimurium SptP which is able to 
act as a bacterial GAP facilitating the hydrolysis of GTP (Fu et al., 1999). 
 
1.2.1.5 Actin polymerization 
 
Figure 6 shows the complex network, controlling the formation of actin riche 
protrusions. In this chapter I would like to focus on the very last step of the cascade, 
the procedure of actin nucleation.  
Figure 6 Organization chart of the signaling network leading to actin structures 
Cytoskeletal reorganization is mainly mediated via the small GTPases Rac1, Cdc42 and RhoA, 
leading to lamellipodia, filopodia and stress fibers respectively. An additional level of complexity is 
added by the fact that the different pathways crosstalk with each other. Cdc42 for instance, is able to 
influence invasive migration or contractility in addition to and independent of filopodia formation. 
The main actin-nucleators are Arp2/3 complex and formins. Arp2/3 is activated by NPFs such as 
N-WASP or WAVE-complex. Actin polymerization via formins is triggered by RhoA (Rottner et al., 
2011). 
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Actin is one of the most abundant proteins in eukaryotic cells. Two forms of this 
ATP-binding protein are present in the cell: 1) is the 42 kDa monomeric globular 
actin (G-actin) and 2) filamentous actin (F-actin) derived from non 
covalent-self-assembly of monomers. These filaments have two asymmetric ends. 
The growing barbed end has a high affinity for filamentous (thus favoring 
polymerization) while the pointed end has a lower affinity for globular actin (thus 
favoring depolymerization in the equilibrium). The difference between (+) and (-) 
end results in a slow treadmilling of subunits (Figure 7). 
 
Figure 7 Assembly and recycling of branched actin filament networks 
The treadmilling model of actin filament assembly and recycling involves the Arp2/3 complex and 
several other proteins which posses regulatory influence on the cycle. At the beginning of the 
cycle an external stimulus (1), signals to cell to move or to alter its shape. The external signal 
triggers a pathway, which at the end activates a NPF (2), which in turn binds to actin and activates 
the Arp2/3 complex, a new filament is initiated (3). These filaments are elongated by incorporation 
of ATP-actin (4), which pushes the membrane forward (5). The elongation stops when capping 
protein binds to the barbed end, preventing the addition of further actin monomers (6). During 
maturation of the filaments (7) hydrolysis of ATP-actin and γ-phosphate dissociation takes place. 
ADF/cofilin promotes dissociation and severs ADP-actin filaments (8). Finally profilin catalyzes 
the ADP for ATP exchange of G-actin (9), refilling the pool of polymerization-competent actin 
(10) waiting for the next round of filament nucleation (Pollard et al., 2003). 
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In case of pure actin filaments, treadmilling results in a forward movement with a 
velocity of 0.04 µm/min. However, under in vivo conditions filaments can grow 
much faster with up to 10 µm/min. The velocity is increased by additional factors 
that facilitate growth. To start a new filament, three monomers have to group 
together to form a nucleation seed called “nucleus”. In principle, the nucleation of 
F-actin can occur spontaneously but it is highly inefficient, since formation of actin 
dimers or trimers is kinetically unfavorable. To solve this problem, actin nucleators 
and so called nucleation promoting factors (NPF) are available in the eukaryotic cell, 
which catalyze the process to overcome the kinetic barrier. For a long time only one 
nucleator, Arp2/3 complex and a few NPFs were known. The past decade however, 
lead to the identification of more NPFs, other nucleators like formins, and further 
proteins involved in actin polymerization. All this can be found in a variety of 
reviews on this topic, for example (Campellone et al., 2010, Goley et al., 2006, 
Pollard et al., 2003, Rotty et al., 2013). 
 
Arp2/3-complex 
The Arp2/3-complex was discovered several times independently in the 1990s, for 
example by affinity chromatography from Acanthamoeba, using the G-actin binding 
protein profiling as affinity matrix (Machesky et al., 1994), or as a human factor 
required for actin-comet tail formation of Listeria monocytogenes (Welch et al., 
1997) and as a essential factor of Cdc42 induced actin filament assembly (Ma et al., 
1998). The complex consists of seven subunits with two actin related components, 
the actin related proteins 2 and 3 (Arp2 and Arp3) (Machesky et al., 1994). The 
subunits Arp2 and Arp3 build a dimer and function as a nucleator by imitating the 
structure of a free (+) end, thus generating a nucleation seed. The complex binds to 
pre existing filaments and is able to generate new filaments by Y-shaped branching, 
afterwards Arp2/3 remains at the pointed end of the new filament (Rouiller et al., 
2008, Mullins et al., 1998). Due to its structural conformation, Arp2/3 on its own is 
rather inefficient in nucleating (Campellone et al., 2010). To increase the nucleation 
efficiency, two things are necessary. The complex has to bind to an existing actin 
filament and it has to be activated by NPFs, resulting in conformational changes 
bringing Arp2 and Arp3 in the right conformation (Goley et al., 2004). 
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Nucleation promoting factors 
The first NPF was discovered in 1998 by Welch and colleagues. They could show 
that the Listeria surface protein ActA is able to activate the Arp2/3 complex, 
resulting in an accelerated actin filament formation. ActA alone was not able to 
generate filaments. They estimated that this mechanism of Arp2/3 activation may 
play a role in the cell too (Welch et al., 1998), which turned out to be true in the 
following years. Today we know that there are two subclasses of NPFs (Figure 8), 
recently reviewed by Rotty and colleagues. All class I NPFs contain a VCA domain, 
which allows G-actin as well as Arp2/3 binding at the same time. This VCA domain 
(also known as WH2 = WASP homology 2 domain) consists of 3 modules: the V = 
verprolin homology, the C = connector and the A = acidic motif. Members of this 
class are WASP, N-WASP, WAVEs and the more resent discovered WASH, 
WHAMM and JMY. Class II NPFs include cortactin and Hs1, they lack the VCA 
domain but nevertheless they are able to bind to Arp2/3 and F-actin instead of 
G-actin. They are thought to have stabilizing effects on existing filaments. Besides 
activating cofactors of the Arp2/3 complex, there are also repressive ones, like 
cofilin or PICK1. Both types of cofactors underlay a tight regulation by various 
signaling pathways (Rotty et al., 2013).   
 
Figure 8 Positive and negative regulation of the Arp2/3 complex  
The Arp2/3 complex initiates new filaments from the side of preexisting mother filaments. For this 
function the complex has to be tightly regulated. The activators, so called nucleation promoting 
factors are divided into two subclasses, containing either directly activating or stabilizing effects. 
The inhibitors execute a lot of different functions, among them filament severing or destabilizing. 
Positive as well as negative cofactors of Arp2/3 underlay the regulation of various signaling 
pathways (Rotty et al., 2013). 
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1.2.2 Defense mechanisms  
Higher organisms are under constant thread of bacteria, viruses and other hazardous 
organisms or toxins. Only very complex self-defense mechanisms secure survival. In 
case of animals, this mechanism is the immune system. In mammals, it is divided 
into two parts, the innate and the adapted immune system. To survive and proliferate 
within the host, pathogens have either to hide or to escape. The mammalian intestine 
is a well studied example of how a host defends against intruders, because this niche 
embodies the zone where the bacteria-containing gut lumen and the sterile body 
adjoin, separated only by a barrier made of a thin layer of epithelia cells. Indeed, 
these cells are the first physical and chemical defense line. If pathogens are able to 
breach this barrier to invade deeper tissues, they face the innate immune system, 
which is represented by different phagocytic cells.  
 
Figure 9 Recognition, phagozytosis and subsequent degradation of pathogens 
Specialized cells for phagocytosis like macrophages or dendritic cells carry receptors on their surface 
that detect certain pathogen related antigens or structures. Upon pathogen recognition, phagocytosis 
takes place (1.). In the next step, the phagosome fuses with lysosomes and the pathogen is degraded 
(2.). After fusion with a MHC carrying vesicle, antigens of the pathogen remnants are prepared for 
antigen presentation (3.). Finally, the loaded MHC is translocated to the cell surface and presents the 
antigen to naïve T cells (4.). 
 
1. 
2. 
3. 
4. 
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During phagocytosis specialized cells, like macrophages, neutrophils and dendritic 
cells, recognize, engulf and digest large particles (Figure 9), for example bacteria 
(Botelho et al., 2011). For obsonized particles the best characterized pathways go via 
the FCγ- or the complement receptor (Caron et al., 1998). In case of non-obsonized 
particles, there are multiple other receptors, including Toll like receptors (TLR) 
(Shen et al., 2010) or the scavenger and mannose receptors (Zhang et al., 2005), that 
can indicate phagocytosis. Pathogens that invade host cells and escape from the 
phagosome, face the autophagy system as the next line of host defense (Yuk et al., 
2012). Although phago- and autophagocytosis belongs to the innate immune system, 
they are also crucial for the activation of adopted immunity. Pathogen derived 
peptides from the phagosome are processed for presentation on major 
histocompatibility complex (MHC). The antigen presenting MHC is translocated to 
the plasma membrane, where naïve T cells are able to recognize the antigen and 
induce the adapted immune response (Kagan et al., 2012). In addition, triggering of 
the TLR or any type of pathogen recognition leads to the activation of inflammatory 
factors, like NF-κB, AP-1 or various cytokines (Medzhitov, 2009). 
 
1.3 Pathogens 
1.3.1 Infection strategies  
Depending on the bacterium, there are different strategies to survive the host´s 
immune response and to establish infection of the host cell. Some bacteria are able to 
evade phagocytosis, either by encapsulation (Neisseria, Streptococcus) or by 
avoiding recognition by receptors (Staphylococcus, Streptococcus). Another 
possibility to avoid phagocytosis is to manipulate the host cytoskeleton to prevent the 
formation of the phagosome (Yersinia, EPEC, EHEC). Other bacteria follow 
different strategies: they allow or even promote phagocytosis and then inhibit 
phagosome maturation (Salmonella, Legionella) or actually live in the harsh 
environment of the mature phagosome (Mycobacterium). Finally, there is the 
possibility to escape from the early phagosome and persist in the cytoplasm (Listeria, 
Shigella) (Sarantis et al., 2012) 
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Figure 10 EPEC mounted on pedestals 
Pseudocolored electron microscope image of 
EPEC (red) sitting on actin rich pedestals 
(Manfred Rhode, HZI Braunschweig) 
 
1.3.2 EPEC/EHEC 
Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC) are 
human pathogens of the intestine which share a unique mechanism to colonize the 
host. They transduce a number of effector proteins via a type III secretion system 
(T3SS) into the host´s cytoplasm (see 1.3.5). These effectors not only result in the 
typical attaching and effacing (A/E) lesions leading to disappearance of the 
microvilli brush border, but also manipulate several other signaling pathways. Both 
strains belong to the family of diarrhoeagenic pathogenic Escherichia coli. EPEC 
(enteropathogenic E.coli) causes gastroenteritis with massive water loss in infants 
while EHEC (enterohemorrhagic E.coli) causes bloody diarrhea. The difference 
between the two pathogens is that EHEC but not EPEC is able to produce Shiga 
toxins. Both bacteria carry a genomic pathogenicity island, the locus of enterocyte 
effacement (LEE) which encodes for the T3SS and several virulence factors, like Tir 
(translocated intimin receptor), Map (mitochondria associated protein) and EspF 
(E.coli secreted protein F) (Wong et al., 2011a, Robins-Browne et al., 2002).  
 
After the first contact of the A/E-pathogen 
with the host´s plasma membrane, the T3SS 
and the first set of secreted proteins like 
EspA, EspB and EspD assemble a 
translocation machine (Knutton et al., 1998, 
Hartland et al., 2000, Ide et al., 2001). This 
machine allows injection of a variety of 
effector proteins into the host cytoplasm. 
Secretion is tightly regulated and follows an 
exact order (Wong et al., 2011a). One of 
the first translocated proteins is Tir. Once in 
the host cytoplasm, Tir becomes 
phosphorylated and integrates into the 
plasma membrane. The extracellular part of Tir then binds to the bacterial surface 
protein intimin (Kenny et al., 1997) leading to a tight connection between the 
bacterium and the cell. Intimin binding, leads to Tir clustering, what in turn triggers 
host signaling pathways, which drive actin polymerization, resulting in actin rich 
pedestals beneath the bacterium (Campellone et al., 2004). Other early translocated 
Introduction 17 
 
effectors are Map and EspT. Both belong to the WxxxE protein family of virulence 
factors (see 1.4) and induce actin cytoskeletal rearrangement within the infected cell 
(Bulgin et al., 2009a, Kenny et al., 2002). 
 
1.3.3 Salmonella 
Salmonella represents a group of Gram-negative bacteria which is currently 
categorized into two species, S. bongori and S. enterica. S. bongori is represented by 
only one subspecies, while S. enterica comprises seven, but only one of them is 
specific to endotherms. The others are restricted to cold blooded animals like reptiles 
(Garai et al., 2012). Here I would like to concentrate on Salmonella enterica serovar 
Typhi and Typhimurium because they serve as common model organisms to study 
host pathogen interaction. Both serovars infect the mammalian intestine and cause 
inflammation and diarrhea. The transmission happens via oral ingestion of 
contaminated food or water. Due to its adaptive acid tolerance, Salmonella is able to 
survive the low pH of the stomach and reach the gut (Garcia-del Portillo et al., 
1993a). In the gut, Salmonella loosely attaches to epithelia cells, translocates 
virulence factors and enters the cells. This can occur via two different routes. In case 
of phagocytes the invasion occurs as described in Figure 9 (Vazquez-Torres et al., 
1999), but Salmonella has also the ability to invade non-phagocytic cells by 
bacterial-mediated endocytosis (Francis et al., 1992).  
 
To achieve being endocytosed by 
non-phagocytic cells, Salmonella injects 
via T3SS (see 1.3.5) a cocktail of virulence 
factors, including SopE, SopE2 and SopB 
(Zhou et al., 2001, Friebel et al., 2001) 
resulting in massive membrane ruffling on 
the host cell surface, and subsequent 
internalization of the bacterium. This 
mechanism is referred to as the “trigger” 
mode of entry, the uptake is very rapid and 
occurs normally within minutes after the 
first stable contact between bacterium and host membrane (Cossart et al., 2004). 
After internalization Salmonella prevents endosomal maturation at stage of the late 
 
Figure 11 Salmonella invades Cos7 cell 
Pseudocolored scanning electron microscopy 
image of Salmonella (yellow) invading the 
host cell (green) by induction of membrane 
ruffling (Rottner et al., 2005) 
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endosome and stays in the so called Salmonella containing vacuole (SCV), 
establishing a unique niche for replication (Haraga et al., 2007). At these later stages 
of infection a second T3SS and another set of virulence factors enter the scene. This 
T3SS II secretes effectors like SifA, SseF and SseJ, which play a role in maintenance 
of the SCV, movement of the SCV towards the perinuclear region and in the 
formation of Salmonella induced filaments (Sifs) (Srikanth et al., 2011, Haraga et al., 
2007). These are long tubular structures, derived from the SCV, spreading 
throughout the whole cell. Sifs are important for SCV positioning, bacterial 
replication and Salmonella pathogenesis in general (Srikanth et al., 2011, Garcia-del 
Portillo et al., 1993b).  
 
1.3.4 Shigella  
The group of Shigella is a genus of gram-negative bacteria which contains four 
serovars. These bacteria infect human and primates via the fecal oral route. They 
cause an acute intestinal infection, with abdominal cramps and severe diarrhea, 
called shigellosis. By rehydration and antibiotic treatment it comes to a rapid 
resolution of the infection. However, in immunocompromised patients or in absents 
of proper healthcare the disease becomes live-threatening (Schroeder et al., 2008). 
 
Figure 12 Actin driven bacterial movement within the host cell. 
In (A) a Listeria infected cell, stained for F-actin in green and for Listeria in red, is shown. The 
bacteria are propelled by actin-comet tails (Gouin et al., 2005). In (B) a close-up of Shigella with 
comet tail is shown, bacteria in blue, N-WASP in green and actin in red (from the homepage of 
Goldmann Lab, Massachusetts). A Shigella actin-comet tail taken with an electron microscope is 
shown in (C) (Gouin et al., 2005). 
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After arrival in the gut, Shigella passes the epithelial barrier via microfold cells, 
immediately followed by macrophage phagocytosis. Within macrophages Shigella 
escapes from degradation by disrupting the phagosomal membrane. In the cytoplasm 
bacteria rapidly multiply and cause cell death. After release from dead macrophages, 
they can enter surrounding enterocytes from the basolateral side by induction of 
ruffling and macropinocytosis (Ogawa et al., 2008). Here Shigella escapes again 
from its membrane envelop and starts replicating in the cytoplasm. To manipulate the 
host cell, Shigella secrets a variety of virulence factors which then target regulatory 
nods of the host. As already mentioned earlier for EPEC and Salmonella, also 
Shigella carries a T3SS allowing secretion of virulence factors directly into the 
cytoplasm of the host (Mattoo et al., 2007). Among those factors are IpgB1 and its 
homologue IpgB2, both target host GTPases and provoke rearrangements of the actin 
cytoskeleton in the early stage of a Shigella infection (Hachani et al., 2007). Another 
secreted factor is IcsA (also known as VirA), this one recruits the actin 
polymerization machinery of the host and induces, like in Listeria, actin-comet tails 
(Figure 12), which propel Shigella forward (Bernardini et al., 1989, Goldberg et al., 
1995, Gouin et al., 2005). 
 
1.3.5 T3SS 
Secretion in general is the process of transduction or release of a chemical substance, 
from a cell or bacterium into the surrounding medium. In Gram-negative bacteria 
there are six different types of secretion systems (Henderson et al., 2004, Pukatzki et 
al., 2006). In this thesis I would like to concentrate on the T3SS which was already 
mentioned in previous paragraphs. The T3SS, also called injectisome, is a needle like 
structure, which is used by pathogenic bacteria to secrete virulence factors into the 
host´s cytoplasm (reviewed in Cornelis 2006). There are seven subfamilies of the 
injectisome. Analysis of their evolution revealed no similarities to development of 
the bacteria, indicating, that T3SS spread by horizontal gene transfer among the 
respective bacteria. Early genetic studies revealed significant similarities to flagella. 
This evidence was later supported by comparison of electron microscope studies of 
Salmonella needle complex and flagella. The architecture of the different injectisome 
subfamilies is more or less the same. Every secretion system consists of a cylindrical 
basal part, called needle complex with an inner and an outer ring that anchors the 
T3SS to the bacterial membrane. On the extracellular side, a needle with a tip 
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complex is formed (Figure 13). Inside the bacterium, a ring of ATPases is associated 
beneath the needle complex. The ATPases are required to deliver the energy for 
secretion. Blocker et al. were able to show, that there is a tunnel of 2-3 nm spanning 
the whole structure from end to end. This core structure is built by nine different 
proteins and a multiplicity of scaffolding proteins facilitating assembly. After the 
injectisome is constructed and connected to the host cell three proteins (IpaB, C and 
D in case of Shigella) are immediately secreted and insert into the host membrane to 
build a pore, the final and essential component of the system. To ensure that 
secretion only occurs into hosts and not spontaneously, this process is strictly 
regulated. Normally secretion is blocked by an inhibiting complex, until a specific 
signal is trigged. Upon signal recipe, which is thought to be the contact with the host 
membrane, expression of effector proteins is boosted, the inhibitor complex falls 
apart and translocation starts (Cornelis, 2006). 
 
Figure 13 Schematic overview of the T3SS 
The T3SS consists of two basic parts. The first is the needle complex, anchoring the whole structure 
with the inner and outer ring to the bacterial membrane. Furthermore it is connected to a ring of 
ATPases which supply the energy for the effector translocation. The extracellular part includes the 
needle, which bridge the distance between bacterium and host cell, the tip complex and the pore, 
which opens the door into the host cytoplasm. Together, this complex machinery allows to 
translocate effector proteins through three membranes and the extracellular space, from the bacterial 
into the host cytoplasm (Cornelis, 2006). 
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1.4 WxxxE 
Many pathogenic bacteria use a T3SS to deliver a variety of virulence factors into the 
host cytoplasm. Here they act as potent regulators and allow the bacteria to directly 
access crucial signaling pathways. In 2006 Alto and his colleagues grouped a new 
family of effector proteins. They recognized a common sequence motive and a 
shared function among several virulence factors from different pathogenic bacteria, 
including Salmonella, Shigella and enteropathogenic E.coli. Using the BLAST 
algorithm for a database search for EPEC Map homologues, they identified several 
proteins, mostly of the A/E group, that shares a Trp-x-x-x-Glu (WxxxE) sequence 
motive. Assuming that this motive contributes to a common function, the authors 
extend the data analysis for WxxxE containing proteins. They came up with 24 
different proteins from pathogenic bacteria. For three of those proteins (Map from 
EPEC and its homologues from Shigella IpgB1 and IpgB2) they could identify a 
common function, leading to characteristic cytoskeleton rearrangements of the host 
cells. Alto came to the conclusion, that all this proteins are, despite any sequence 
similarities, functional mimics of small Rho family-GTPases (Alto et al., 2006). 
Today we know, that this conclusion does not hold true. A database based on the 
structure of SifA identified SopE, an already known bacterial GEF mimic (Hardt et 
al., 1998), as the closest known structural relative of SifA.  
 
Figure 14 Structural comparison of bacterial and human GEFs 
The fold of the two bacterial GEFs SopE from Salmonella and Map from pathogenic E.coli is in large 
parts superposable. Although there is no sequence similarity, especially the catalytic loops (orange) are 
closely related. In case of Map, the Trp and Glu residues of the WxxxE motive are highlighted in 
yellow. As a representative for human GEFs ITSN is depicted on the right side. Its folding differs 
completely from SopE and Map (Orchard et al., 2012a).  
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This finding and the fact that SifA binds to GDP- and not to GTP-bound RhoA only 
allows to conclude, that WxxxE family members do not function, as GTPase mimics 
but as bacterial GEFs (Ohlson et al., 2008). Interestingly there is no similarity in 
sequence or fold between SifA and SopE or any known eukaryotic GEF.  
In 2009 Huang and his co-workers could for the first time show in 2.3-Å resolution, 
that the EPEC effector Map forms selectively a complex with Cdc42. Furthermore 
they could show in vitro that Map function as a potent guanine nucleotide exchange 
factor for Cdc42 (Huang et al., 2009). However, these results still left open the 
mechanism, of how members of the WxxxE family are able to catalyze the 
GDP-GTP exchange in GTPases. This last gap was closed when Klink and fellows 
where able to solve the crystal structure of every single step of the nucleotide 
exchange for the IpgB2-RhoA complex (Klink et al., 2010). Although the knowledge 
gained in the last years on the WxxxE family is enormous (Bulgin et al., 2010, 
Aktories, 2011, Orchard et al., 2012a), there are still lots of open questions. 
Especially the regulatory influence of host proteins on the virulence factors is largely 
unknown. In the following paragraphs I would like to introduce some of the WxxxE 
family members which are subject to this study, in more detail. 
  
1.4.1 Map 
One WxxxE member is the type three secreted virulence factor Map. It is present in 
bacteria of the A/E group, like EPEC, EHEC and C.rodentium and was first 
identified as a mitochondria associated protein, involved in the disruption of 
membrane potential (Kenny et al., 2000). Two years later, it was reported that Map is 
sufficient to induce filopodia during the early stages of EPEC infection, independent 
of Tir (Kenny et al., 2002). Later it was shown, that Map selectively targets and 
activates Cdc42 to induce filopodia formation. Furthermore the binding of Map to 
ezrin/radixin/moesin (ERM)-binding phosphoprotein 50 (EBP50), also known as 
Na+/H+exchanger regulatory factor 1 (NHERF1) was described to be important to 
stabilize Map-induced filopodia (Berger et al., 2009). Map binds to EBP50 via its 
carboxy-terminal PSD-95/Disk-large/ZO-1 (PDZ)-binding motif (Simpson et al., 
2006).  
In this study we follow results from an initial yeast two hybrid (Y2H) screen 
indicating that Map might interact with the human RhoA binding protein rophillin1 
(RHPN1). Only little is known about rhophilins, which comprise 2 members, 
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RHPN1 and RHPN2 in mammals. Both proteins were reported to target RhoA 
GTPases in order to regulate actin cytoskeleton organization (Watanabe et al., 1996, 
Peck et al., 2002). According to SMART protein domain prediction web tool, the 
two homologues contain a HR1 domain, which is known to mediate interactions with 
small GTPases. Furthermore both rhophilins possess a Bro domain which is 
implicated to be involved in endosomal targeting. This domain is quite interesting, 
because it gives room to speculations about a potential involvement of the ESCRT III 
complex in EPEC infection. Since it was reported that enveloped viruses are able to 
recruit the ESCRT III machinery by targeting the human Bro domain containing 
protein Alix, to facilitate virus budding (Strack et al., 2003, Morita et al., 2011, 
Boonyaratanakornkit et al., 2013, Popov et al., 2009). Finally, both RHPN isoforms 
comprise a PDZ domain, which could serve as the interaction surface between RHPN 
and Map.  
 
1.4.2 EspT 
Another, but very rare T3SS effector of A/E pathogens is EspT. According to 
surveys on clinical isolates of EPEC and EHEC, only 2 % of the EPEC strains 
contain EspT (Arbeloa et al., 2009). In 2009 it was identified by Bulgin and 
colleagues, as a novel member of the WxxxE protein family. They reported that 
ectopic expression of EspT from C.rodentium results in lamellipodia or ruffle 
formation, depending on the tested cell type. These rearrangements of actin were 
interpreted to result from ELMO- and Dock180-independent targeting of Rac and 
Cdc42 (Bulgin et al., 2009b). During EPEC infection the effector is able to provoke 
membrane ruffling on the host surface, resulting in the invasion of non-phagocytic 
cells (Bulgin et al., 2009a). In this study the internalized bacteria resided in the 
phagosome where they induce intracellular pedestals. Another study revealed a role 
of EspT in the regulation of immune mediator production. Via extracellular signal-
regulated kinases (Erk), c-Jun N-terminal kinases (JNK) and NF-kB it stimulates the 
secretion of Il-1β, Il-8 and PGE2 (Raymond et al., 2011). 
In our previous mentioned Y2H screen we got several hints for putative interaction 
partners from the host side. We decided to focus on the interaction with Arf6, 
because it is a small GTPase that might be regulated by this GEF mimic. 
Furthermore Arf6 was described to be involved in reorganization of the actin 
cytoskeleton and in membrane trafficking, facilitating phagocytosis (Donaldson, 
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2003, D'Souza-Schorey et al., 2006). Both are functions which could be of interest 
for pathogens.   
 
1.4.3 SifA/B 
SifA and SifB from Salmonella are two of the originally identified WxxxE family 
members (Alto et al., 2006) but different from the other family members, in that they 
seem to be not involved in actin dynamics (Bulgin et al., 2010). SifA is secreted via 
the second T3SS, localizes at the phagosome and is required for its tabulation (Stein 
et al., 1996). While SifA is necessary to deploy full virulence in macrophages and 
mice (Beuzon et al., 2000), the role of SifB during pathogenicity remains still 
unknown and is under ongoing research. Finally, SifA and –B display a long 
N-terminal extension that is essential to the phagosome function. Ohlson et al. were 
able to show that SifA consists of two domains, one binding to the host protein SKIP, 
an interaction essential for the maintenance of the SCV (Boucrot et al., 2005), and 
the other containing the WxxxE motive (Ohlson et al., 2008). Although SifA shares a 
common fold with other bacterial GEFs like Map or SopE (Ohlson et al., 2008), no 
GEF function could be demonstrated for SifA yet (Orchard et al., 2012a). 
In our Y2H screen we got only five putative interaction partners for SifB, including 
Cdc42 and Rac1. In case of SifA we got more than 30 predicted interactions, among 
them the Rap GTPase interactor RADIL, the adapter protein of the Toll-like and IL-1 
receptor signaling pathway ECSIT, or SPIRE1, a protein involved in actin 
organization (see result section 2.1 and 2.2.4).  
 
1.4.4 IpgB1/2 
The two Shigella effector proteins IpgB1 and IpgB2 are encoded on the Shigella 
virulence plasmid (Parsot, 2005). Both of them belong to the type three secreted 
virulence factor WxxxE family (Alto et al., 2006). Ectopic expression of IpgB2 was 
reported to induce stress fibers, while IpgB1 stimulates the formation of lamellipodia 
and ruffles (Ohya et al., 2005, Alto et al., 2006). Later it was shown that IpgB1 
promotes bacterial entry by triggering ruffle formation and activating Rac1 via the 
ELMO-Dock-180 pathway (Handa et al., 2007). Infection studies, using deletion 
mutants for IpgB1 and IpgB2, revealed different effects on pathogenicity of those 
proteins with respect to the infected cell line or organism (Hachani et al., 2008). 
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More recent studies show that IpgB1 function as a GEF for Rac1 and Cdc42, while 
IpgB2 is able to catalyze the nucleotide exchange on RhoA (Huang et al., 2009, 
Klink et al., 2010). 
In our Y2H screen we found no interactions of IpgB1 together with any host protein. 
In case of IpgB2 this was different here we got hits for BBS4 and TRAPPC6A. 
BBS4 is a component of the BBSome, a multiprotein complex located at the primary 
cilium and at centriolar satellites (Loktev et al., 2008, Nachury et al., 2007). 
TRAPPC6A is also a multiprotein complex subunit, the TRAPP I complex is 
involved in vesicular transport at the endoplasmic reticulum (Sacher et al., 2008). 
 
1.5 Aim 
The research of the last decade accumulates more and more knowledge about the 
very complex molecular processes, on the bacterial side, leading to infectious 
diseases. One landmark in the understanding host-pathogen-interactions was the 
discovery of the WxxxE family of bacterial virulence factors. Their function as 
bacterial GEFs allows pathogens not only to target single proteins, but total signaling 
cascades and thereby the direct control on multiple cellular functions from 
endocytosis over motility till apoptosis. Since the regulation of mammalian GEFs is 
quite tight and the number of translocated virulence factors is rather low, it is most 
likely that host adapter- or scaffolding proteins are involved in the regulation of 
bacterial GEFs. It is the right time to find out what these proteins are and how they 
participate in regulation during infection. To tackle this question we started this study 
with a large scale Y2H screen to identify so far unknown interaction partners of 
WxxxE family members. Subsequently we here try to verify these potential hits by 
using biochemical and microscopic methods. 
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2 Results 
2.1 Y2H screen 
At the start of this study, we initiated a large scale Y2H screen to identify novel host 
targets of different bacterial virulence factors. The screening was performed in 
collaboration with Manfred Kögl and Frank Schwarz from the German Cancer 
Research Center in Heidelberg. As bait proteins we used full length, or truncated and 
mutated versions of Salmonella enterica serovar Typhimurium SifA, SifB, SopB, 
SopE and SopE2. Furthermore, we included IpgB1 and IpgB2 from Shigella flexneri, 
as well as Map and EspT from EPEC and Citerobacter rodentium. A human 
cDNA-based protein library served as prey. Each result was categorized in one of 
four groups: certain interactions, if a specific bait prey interaction occurs more 
frequently; uncertain interactions, if a specific bait prey interaction occurs only once; 
likely false positives, based on empirical data, if a prey is “sticky”, and thus 
frequently found in different screenings (prey promiscuity) and finally false 
positives, if the prey protein contains UTR elements. For more detailed information 
on data evaluation see (Albers et al., 2005). The output of the screen was diverse: 
when grouping the certain and uncertain hits for all different variants of one bait 
protein, the numbers differed from 68 hits (e.g. SifA) to zero (SopE or IpgB1). 
Interestingly, among the 40 certain and uncertain hits for EspT from C. rodentium 
and EPEC only four could be found for EspT of both bacteria. With its appearance in 
three different approaches the transcription factor HOXA1 was the most frequently 
found among the certain hits. Only the transposable element TIGD1 and the zinc 
finger protein 343 were more frequently isolated (both four times) but they belong to 
the likely false positive group. Out of all 185 potential interaction partners we pre-
selected those which possess known functions in processes like migration, 
endocytosis, or cellular transport (Table 1).  
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Table 1 Pre-selected list of Y2H results 
Bait Prey 
No. of 
Isolations 
Prey 
promiscuity 
Prey function 
Map NHERF-2 8 2 Scaffolding protein 
 RHPN1 2 2 RhoA interactor 
 Spire1 1 4 WH2 protein involved in actin organization 
EspT Arf6 2 3 Small GTPase 
 Appl1 2 2 Adapter protein involved in cell proliferation 
 Cep70 2 5 Organization of the mitotic spindle 
IpgB2 BBS4 2 1 Cilia formation; microtubule-related transport 
 TRAPPC6A 2 4 Trafficking protein particle complex subunit 
SifA ECSIT 4 2 Signaling intermediate 
 RADIL 2 1 Effector of Rap in migration and adhesion 
 Spire1 1 4 WH2 protein involved in actin organization 
 Cep70 1 5 Organization of the mitotic spindle 
SifB Cdc42 60 3 Small GTPase 
 Rac1 1 3 Small GTPase 
SopB HGS 45 7 Recycling of membrane receptors 
 ATP6V1E1 12 3 Subunit of the ATPase 
 SNX6 3 3 Intracellular trafficking 
Rab11A 1 7 Small GTPase 
 
2.2 Recombinant proteins and subsequent pull down assays 
In order to prepare recombinant proteins, a plasmid carrying the gene encoding for 
the protein of interest was transformed into the E.coli protein expression strain BL21. 
The purification protocol varied depending on the used protein tag and on the 
properties of the specific protein. After purification, the samples were loaded and ran 
on a SDS-PAGE and subsequently stained with Coomassie Brilliant Blue to 
determine efficiency of expression, purity and concentration. When available, known 
interactors were used as positive controls in pull down assays, before the other 
experiments were started. 
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2.2.1 EspT and its putative interactors 
 
After disintegration of the cells by sonication and subsequent centrifugation, the 
majority of the EspT protein remained in the insoluble fraction and could be found in 
the pellet (Figure 15). Nevertheless, the preparation of EspT beads from both 
bacteria C.rodentium (Figure 15 A) and EPEC (Figure 15 B) revealed enough pure 
protein. For later pull down experiments 30 µl of bead material were used. 
One of the putative interaction partners for EspT from Citerobacter was the small 
GTPase Arf6. This member of the Ras-superfamily has been reported to be involved 
in several cellular processes, including reorganization of the actin cytoskeleton and 
endocytosis (Donaldson, 2003, D'Souza-Schorey et al., 2006) 
To confirm this interaction, we performed pull down assays using a constitutive 
active and different dominant negative mutants as well as the wild type version of 
C-terminal GFP tagged Arf6 (Figure 16). Furthermore, it was described that Rac1 
and Cdc42 are substrates of EspT, but a direct interaction has not been shown so far 
(Bulgin et al., 2009b, Orchard et al., 2012a). Therefore, we performed also pull 
downs with these GTPases (Figure 17). 
 
 
Figure 15 Coomassie stained SDS-PAGE of EspT protein purification 
EspT (with tag 67 kDa) from C.rodentium (A) and EPEC (B) were both expressed from the 
pETM-41 His-MBP vector. Induction was performed overnight using 0.5 mM IPTG at 20°C. Huge 
amounts of the proteins after super-sonication (SS) and centrifugation were found in the pellet 
(insoluble fraction) and only traces could be found in the supernatant (SN). Nonetheless, the bands 
in the bead lanes are pure and robust. 
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The pull down experiments were performed using the constitutive active Arf6 Q67L 
mutant, or the dominant negative variants T27N, T44N, T157N and WT. To exclude 
interactions between His-MBP and the GTPases, the immobilized tag was used for 
control pull down assays. Each approach was run in triplicates and in every case, no 
direct interaction could be detected. Sometimes very weak bands, like seen in the 
T157N pull down of Figure 16 A (right), were observed. To ensure, that no 
interaction was washed away by triton X-100, one stet of pull down assays was 
performed, using a washing buffer lacking triton. The result of these experiments did 
not differ from the experiments including triton. Exemplarily the Arf6 T27N pull 
down without use of triton is shown in Figure 16 B. An attempt with EspT beads 
from EPEC showed the same result. 
 
 
 
 
Figure 16 No interaction between Arf6 and EspT in pull down experiments 
Western blot analysis after pull down assay using wild type (WT), constitutive active (mutation QL) 
and different dominant negative (mutation TN) versions of Arf6 are shown. The experiments were 
performed using EspT from C.rodentium (left) and non-fused His-MBP (right). The proteins were 
detected by a polyclonal GFP antibody. There are robust signals in the load controls and in 
supernatant after pull down (SAP). The respective pull down lanes are empty. In (A) the standard 
triton X-100 containing washing buffer was used, in (B) no triton was used. Asterisks indicate weak 
interactions. 
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To address the question whether Rho GTPases can interact with EspT directly, pull 
down assays with EspT from Citerobacter against WT, CA and DN versions of Rac1 
and Cdc42 were performed. This set of experiments included also WT RhoG from 
mouse, human RhoG G12V/T17N and CA and DN RhoA (Figure 17). 
 
In pull down experiments with constitutive active versions of Rac1 and Cdc42, 
regardless whether EspT or one of the GTPases was used as bait or pray protein, 
always a strong interaction between the tested proteins was observed (Figure 17 
A+C). The result was different in case of other GTPase variants. Interestingly, no 
interaction between EspT and dominant negative versions of Cdc42 and Rac1 could 
be observed. This was a surprise, because EspT as potential GEF mimic which 
provokes reorganization of the actin cytoskeleton in the host cell was expected to 
interact especially with dominant negative GDP loaded GTPases. In an attempt using 
Myc-tagged WT versions of Rac1 and Cdc42, both showed only weak interactions 
with EspT. The experiments concerning CA RhoA showed a weak or no interaction 
 
Figure 17 EspT interacts with constitutive active Rac1 and Cdc42 
Immobilized EspT from Citerobacter rodentium was used in pull down assays against different 
versions of Myc-tagged (A) and GFP-tagged (B) GTPases. The clearly positive interactions with 
Cdc42 QL and Rac1 QL were double checked in a vice versa experiment (C), which gave the same 
result. 
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with EspT, the DN version no interaction. Also using RhoG revealed no interaction 
with EspT, no matter which version was tested (Figure 17 B). However, the RhoA 
and RhoG experiments were not yet performed in triplicates, further pull down 
assays have to be done. 
 
2.2.2 SopB and its putative interactors 
 
The efficiency of the SopB purification was rather low, after the incubation with the 
bead material, still high amounts of the protein remained in the supernatant. 
Nevertheless, SopB concentration on the beads was sufficient (Figure 18) and for 
subsequent experiments 30 µl of the beads were used. 
Based upon our Y2H screening the subunit ATP6V1E1 of the V-ATPase is a 
potential interactor of SopB. However, in pull down experiments a direct interaction 
between these two proteins could not be detected (Figure 19). 
To test whether there is truly no interaction between both proteins or if there might 
be an experimental problem, such as misfolding of SopB, we tried to reproduce the 
known interaction between SopB and Cdc42 (Rodriguez-Escudero et al., 2011, 
Burkinshaw et al., 2012) 
 
 
 
Figure 18 Coomassie stained SDS-PAGE of SopB protein purification 
SopB (with tag 106 kDa) from Salmonella enterica was expressed in the pETM-41 vector and 
purified in E.coli BL21 after 4 h induction at 37°C. After sonication and incubation with the bead 
material, huge amounts of the protein could be found in the supernatant. However, the SopB 
concentration on the beads seems to be sufficient.  
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Our SopB beads show strong interactions with constitutive active as well as 
dominant negative Cdc42, as shown before in yeast (Rodriguez-Escudero et al., 
2011). Furthermore the same experiments were performed with the Rho GTPases 
Rac1 and RhoA. Again, as shown in yeast, in these cases almost no interaction could 
be detected (Rodriguez-Escudero et al., 2011). 
 
2.2.3 IpgB1/2 and its putative interactors 
After successful purification of IpgB1 and IpgB2 (Figure 20), 30 µl and 10 µl of the 
beads were used in pull down experiments, respectively. Since there was no result for 
a possible IpgB1 interactor in our Y2H screen, we only tested these beads against the 
already published interactors Rac1 and Cdc42 (Huang et al., 2009). However, in our 
hands, after five independent experiments, using dominant negative mutants, no 
interaction could be detected (Figure 21). The same was true for using constitutive 
active mutants. We found the same negative result for RhoA and RhoG. 
 
Figure 19 No interaction between the V-ATPase subunit and SopB 
The pull down experiments revealed no interaction of SopB with the GFP-tagged V-ATPase subunit. 
In contrast the interaction with Myc-tagged Cdc42 is strong, while there is almost no interaction with 
Rac1 and RhoA. 
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Figure 20 Coomassie stained SDS-PAGE of IpgB1 and IpgB2 protein purification 
Both proteins (around 70 kDa with tag) are equally well expressed after 4 h IPTG induction at 37°C. 
However, under the used conditions, IpgB2 seems to bind more efficient to the beads compared to 
IpgB1. 
 
 
Figure 21 No interaction between Cdc42, Rac1 or RhoA and IpgB1 
The pull down experiments between IpgB1 on the one hand and Cdc42, Rac1 and RhoA on the other 
hand did not reveal any interaction.  
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In contrast to IpgB1, we identified the putative interaction partners BBS4 and 
TRAPPC6A for IpgB2 in the Y2H screen. Recombinant IpgB2 was successfully 
expressed before (Klink et al., 2010) in our group. In an initial experiment, 
GFP-tagged BBS4 was tested to be pulled down by recombinant IpgB2, however, no 
interaction could be found (Figure 22 A, upper panel) However, when recombinant 
BBS4 linked to beads was used in pull downs against IpgB2-GFP (Figure 22 B), we 
were able to show a clear interaction. We were not able to confirm the second Y2H 
hit of an IpgB2/TRAPPC6A interaction (Figure 22 A, upper panel). The positive 
control, dominant negative RhoA (Klink et al., 2010) did interact with the virulence 
factor (Figure 22 A, lower panel). 
 
 
Figure 22 BBS4 and IpgB2 interact in pull down assays if IpgB2 is the bait 
(A) The pull down experiments between His-MBP tagged IpgB2 and GFP tagged BBS4 as well as 
GFP tagged TRAPPC6A showed no interaction. The positive control, using immobilized 
RhoA T17N was positive. (B) If His-MBP bound BBS4 was used to pull down IpgB2, a clear 
interaction could be observed. 
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2.2.4 SifA/B and its putative interactors 
The yield of recombinant SifA was rather high, the protein was well expressed, 
soluble under our buffer conditions and bound with high affinity to the 
Ni-NTA-beads. For SifB this was totally different. Under other conditions the whole 
protein could be detected after sonication and centrifugation only in the pellet. 
Finally, we identified conditions, where a small amount of protein remained soluble 
and was capable of binding to the beads (Figure 23, lower panel). 
 
Since the only published interactor of the putative GEF-domain of SifA is the 
GDP-loaded small GTPase RhoA and even none is known for SifB (Ohlson et al., 
2008, Orchard et al., 2012a), we tested both virulence factors for interactions with 
the small Rho GTPases Cdc42, Rac1 and RhoA (Figure 24). This was supported by 
the Y2H hit for a putative interaction between SifB and Cdc42. However, no 
interactions were detected for SifB and only weak interactions (marked with 
asterisks) were observed for SifA in combination with CA and DN Rac1. 
 
 
 
 
 
Figure 23 Coomassie stained SDS-PAGE of SifA and SifB protein purification 
Both His-MBP tagged proteins (around 70 kDa with tag) are equally well expressed after 4 h IPTG 
induction at 20°C. However, under the used conditions, SifA seems to bind more efficient to the 
beads while lots of SifB is bound in the insoluble fraction.  
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Furthermore we attempted to detect interactions between SifA and SifB together with 
different members of the Rab GTPase family in pull down assays. This was of 
interest since the Rab proteins are involved in vesicular trafficking and so 
consequently participated in the maturation of the SCV. Moreover the formation of 
Sifs is dependent on Rab7 and Rab9 (Brumell et al., 2007) and since the same is true 
for SifA, an interaction on protein level could be possible. 
We were not able to show an interaction of any of the tested Rab GTPases with SifB. 
In case of SifA pull downs, we observed that Rab9a bound to SifA, at least in several 
of the experiments. Additionally we could exclude interactions with Rab4a, Rab5a 
and Rab7a. Data concerning Rab11a were not reproducibly positive or negative and 
thus did not allow a reliable conclusion (Figure 25). 
 
 
 
 
Figure 24 Neither SifA nor SifB interact with any form of Cdc42, Rac1 or RhoA 
In pull down assays using immobilized SifA or SifB against dominant negative or constitutive active 
versions of Cdc42, Rac1 and RhoA, we could not observe any interactions. Asterisks indicate weak 
interactions. 
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2.2.5 Map and its putative interactors 
From the list of potential interactors of Map, RHPN1 was chosen not at least due to 
the fact that it harbors a PDZ-domain (Peck et al., 2002), while Map possess a PDZ 
binding motif (Alto et al., 2006) To analyze the putative interaction between Map 
and RHPN1, both proteins were expressed in E.coli BL21 as recombinant fusion 
proteins (Figure 26). While Map was linked to a His-MBP tag and purified by 
Ni-NTA sepharose, the human RHPN1 protein was expressed and purified as a GST 
fusion protein. The availability of both proteins in an immobilized way allowed 
doing the experiments in vise versa approaches, which increased the reliability of the 
results.  
Beside the putative interaction with RHPN1 we tested also the ability of Map to 
interact with the small GTPase Cdc42, which should serve as a positive control, since 
its interaction with the virulence factor has already been described (Huang et al., 
2009). 
 
Figure 25 Pull down experiments of different Rab GTPases versus SifA and SifB 
In pull down assays using immobilized His-MBP tagged SifA and SifB against GFP fused WT Rab 
GTPases, SifB did not interact with any of the five tested Rabs. The same was true for SifA in pull 
downs with Rab4a, 5a, and 7a. Only Rab9a shows frequently interactions with SifA. Results of 
Rab11a were not consistent enough to allow a reliable conclusion 
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We showed that the positive control between Map and Cdc42 worked (Figure 27) in 
more than 50 % of all experiments, while the negative controls using GFP alone 
against Cdc42 beads or immobilized His-MBP against Myc tagged Cdc42 were 
always negative. Since it is known, that RHPN1 is a downstream effector of the 
small GTPase RhoA (Watanabe et al., 1996), we used RhoA in pull down 
 
Figure 26 Coomassie stained SDS-PAGE of human RHMN1 and Map protein purification 
E.coli BL21 bacteria, expressing the RHPN1-GST fusion protein (100 kDa with tag), were lysed 6 h 
after IPTG induction at 20°C. After cell breakup, the lysate was incubated with glutathione 
sepharose to allow GST binding. The resulting protein concentration is shown in the last three lanes. 
The Map His-MBP fusion protein needed an IPTG induction time of 20 h at 20°C to achieve 
appropriate amounts of the protein. Under the chosen conditions Map is highly soluble and bound 
with high affinity to the bead material.  
 
 
 
Figure 27 Map interacts with Cdc42 in pull down experiments 
In the upper row, Myc tagged Cdc42 T17N expressing B16 cells were lysed and a pull down 
experiment against immobilized His-MBP tagged Map performed. The Western blot revealed a clear 
interaction between both proteins. In the row below, the vice versa experiment is shown. Here, a 
Map-GFP containing lysate was pulled against immobilized dominant negative GST tagged Cdc42. 
Again an interaction could be detected in the Western blot.  
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experiments as a positive control. Concurrently we tested against Cdc42 and Rac1 
for interactions. Beside the expected interaction of RHPN1 and RhoA, we found an 
unexpected strong interaction with constitutive active Rac1 (Figure 28 A+B) as well 
as a weaker interaction with constitutive active Cdc42 and dominant negative Rac1. 
 
 
Figure 28 RHPN1 interacts with RhoA and Rac1 in pull down experiments 
In pull down assays using GFP tagged RHPN1 against different small Rho GTPases the Western 
blot revealed strong interactions with constitutive active Rac1 and both, CA and DN RhoA (A+B). 
The vise versa experiment, using Myc-tagged GTPases, showed no interactions (C). 
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Only the pull downs with dominant negative Cdc42 and the GST negative control 
revealed no interaction in the Western blot. Interestingly these results arise from 
experiments using immobilized GTPases. In cases if RHPN1 was bound to beads, no 
interaction to any GTPase could be observed (Figure 28 C), maybe because 
recombinant RHPN1 is not properly folded in bacteria, at least its GTPase binding 
domain HR1 is possibly not functional.  
We next tried to verify the putative interaction between Map and RHPN1 in pull 
down experiments. As before in the Map-Cdc42 experiment, again vice versa 
approaches were performed.  
 
 
Figure 29 Map and RHPN1 are able to interact in pull down experiments 
In (A), lysates of cells expressing GFP labeled human RHPN1, human RHPN2 or mouse RHPN1 
were used for pull down experiments against immobilized His-MBP tagged Map. The Western blot 
revealed that Map clearly interacts with RHPN1, but not with RHPN2. Also an interaction with 
mouse RHPN1 was observed. The control pull down using GFP alone, stayed clear. Below in (B), a 
GFP tagged Map containing lysate was pulled against immobilized GST tagged RHPN1. The result 
was the same as in the vice versa approach above. 
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By using cell lysates of B16 cells transfected with GFP tagged RHPN1 for pull down 
experiments against immobilized His-MBP tagged Map, in all of the five 
independently performed approaches the Western blot revealed a clear interaction 
between both proteins. Additionally, also a clear interaction between mouse RHPN1 
and Map was observed (Figure 29 A). In case of the vice versa experiment, GFP 
tagged Map against immobilized GST-RHPN1, more than half of all pull down 
revealed an interaction (Figure 29 B). Pull down assays against the second human 
rhophilin RHPN2, did not show any interactions between Map and RHPN2. Again, 
the proper folding of the recombinant full length RHPN1 may be causative of these 
negative results. 
 
Figure 30 The PDZ domain of human RHPN1 binds exclusively to Map 
In (A), again the interaction of GFP tagged RHPN1 to immobilized His-MBP tagged Map is shown. 
Furthermore you could see pull downs of the RHPN1 domains BRO, HR1 and PDZ against Map. 
The Western blot revealed that only the PDZ domain is able to bind to the virulence factor. The pull 
down experiments shown in figure (B) could not detect interactions of His-MBP tagged Map to 
further GFP-PDZ domains. However, the functionality of the single PDZ domains was not tested. 
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After verifying the interaction between the virulence factor Map and the human 
RhoA interactor RHPN1, we turned to the identification of the interaction surface 
between both proteins. Therefore GFP tagged domain constructs of human RHPN1 
were designed and tested in pull downs against immobilized recombinant Map. 
Western blot analyses showed, that the RHPN1-PDZ domain was the only isolated 
protein domain, which was able to interact with Map (Figure 30 A).  
The exclusiveness of this interaction was highlighted by the negative results of pull 
down experiments against other PDZ domains from human RHPN2, mouse RHPN2 
or the PDZ domain of RADIL, which has been tested as a rhophilin unrelated control 
(Figure 30 B). Surprisingly, also mouse RHPN1 showed a negative result in pull 
down assays against Map, although we observed interactions with the full length 
protein (Figure 29 A). Since no interactor of these PDZ domains was known or 
available, therefore the functionality could not be tested. Experimental 
insufficiencies like miss folded recombinant proteins could not be excluded.  
 
2.2.6 Rhophilin CHMP4b interaction 
 
 
Figure 31 CHMP4b antibody test 
In order to test the efficiency of the abcam® CHMP4b antibody, we run a SDS-PAGE with lysates 
of the indicated cell lines and performed the Western blot. Subsequent antibody detection (A) 
revealed a strong unidentified band at 35 kDa and one or two weak bands around 25 kDa. CHMP4b 
is expected to migrate at 27 kDa. The band marked with an asterisk is assumed to correspond to 
CHMP4. Pull down assays (B) of B16 cell lysates against immobilized human RHPN1 revealed no 
clear result, because of the high background signal. Potentially a weak interaction is present. 
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To analyze the potential link between Map, RHPN1 and the ESCRT III complex, we 
tested two CHMP4b specific antibodies, sc-134946 (Santa Cruz) and ab105767 
(abcam®). CHMP4b is one subunit of the ESCRT III complex, which is able to 
interact with Bro domain containing proteins (Boonyaratanakornkit et al., 2013). 
First, we tested the antibodies against lysates of different cell lines. Results of the 
abcam® antibody are exemplarily in Figure 31 A. 
According to the expected size of 27 kDa for CHMP4b, lysates of 39er or B16 cells 
seemed to be most suitable to perform pull down assays against human RHPN1. Pull 
down assays using B16 cell lysates against immobilized human RHPN1 revealed no 
convincing result, because the antibody detection repeatedly produced high 
background signals (Figure 31 B). In our hands, both antibodies did not work 
satisfactory in biochemical experiments. Further experiments are needed to clarify 
this issue.  
 
2.3 Co-immunoprecipitations 
To further support the results of the pull down experiments between Map and 
RHPN1, we decided to perform co-IPs. Therefore we used Myc tagged Map and 
GFP tagged human RHPN1. After co-transfection into B16 cells and subsequent cell 
lysis, we either used 5 µg of GFP antibody to link RHPN1 to bead material, or 200 µl 
of an anti Myc supernatant or directly beads, coated with Myc antibody to 
immobilize Map. The control blots of each IP showed that at least in two of three 
cases the antibody recruitment of the bait protein to the beads was successful.  
After GFP detection of the GFP IP, we saw a strong signal for the RHPN1-GFP 
protein around 100 kDa. Also the Myc staining of the Myc-bead IP revealed a weak 
but clear band. Only in case of the Myc antibody IP we were not able to show 
precipitation of RHPN1. Since it was repeatedly hard to detect any bands (also load 
or SAP control) in these experiments, there had to be a general technical problem. 
When, using the Myc coated beats, at least 50 % of the experiments resulted in a 
clear RHPN1 precipitation (Figure 32). When we were performing the experiment 
with immobilized RHPN1, we always got a strong 25 kDa signal in the IP lane. 
Unfortunately, the antibody light chain is migrating at the same height and the 
specificity of our Myc antibody is not focused enough. Because of this we could 
never be totally sure if we were looking at a Map precipitation, or a cross-reaction. 
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Subcloning of RHPN1 in Myc- or HA-vectors and the usage of Map-GFP will solve 
this issue in the future. 
 
2.4 Microscopy 
2.4.1 Influence of WxxxE proteins on the actin cytoskeleton   
Since many members of the WxxxE virulence factor family are known to function as 
bacterial GEF mimics and because of this function being tightly knotted to GTPases, 
it is mandatory to understand the host cell morphology subsequent to virulence factor 
and GTPase transfection.  
To compare the effect to continuous activity of Rho family GTPases on the 
morphology of the cell, overexpression of constitutive active Rac1, Cdc42 or RhoA 
mutants in Hela cells followed by subsequent phalloidin staining of the actin 
cytoskeleton was performed (Figure 33). In all following microscopy panels, DAPI 
staining is only shown in the merge, except for some infection assays. The 
overexpression of CA Rac1 resulted in the typical wide spread cells, with large 
fan-shaped lamellipodia at the cell periphery. The ectopic long term expression of 
CA Cdc42 induced a phenotype similar to that of Rac1 expressing cells, due to the 
crosstalk in the GTPase pathways and numerous fine stress fibers. Finally, the 
overexpression of CA RhoA results in an enhanced formation of thicker stress fibers.  
 
 
Figure 32 Co-IP experiments between RHPN1 and Map supported our pull down results 
Two IPs, realized with anti GFP antibody, or with anti Myc coated beads (from top to bottom). 
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As described above for the small Rho GTPases, all the virulence factors of this study 
were transiently transfected into Hela cells, followed by fixation, phalloidin staining 
and DAPI staining. Also cells transfected with GFP alone were analyzed (Figure 34, 
upper panel), to ensure that the tag had no effect. Overexpression of EspT (Figure 34, 
middle) resulted in a Rac1-like phenotype, wide spread cells, with prominent 
lamellipodia at the cell front. This observation was virtually identical with either 
EspT from EPEC or from C.rodentium. The only difference between both proteins 
was, that EspT from EPEC was more equally distributed throughout the cytoplasm, 
while the Citerobacter protein was frequently observed to localize in smaller spots 
close to the nucleus (Figure 34, middle).  
In case of SopB it is difficult to describe the cell morphology upon transfection, 
because this protein seems to be highly toxic to the cells. The standard transfection 
protocol, used for all the other virulence factors was not applicable. Indeed, the 
 
Figure 33 Hela cells, ectopically expressing constitutive active Rac1, Cdc42 and RhoA 
Hela cells were transiently transfected with Myc tagged Rac1 Q61L, Cdc42 Q61L or RhoA G14V. 
After fixation, transfected cells were identified using antibody staining (green). Red labeled 
phalloidin was used to stain the actin cytoskeleton and DAPI for the nucleus. The cells were imaged 
at a 60 x resolution and the scale bar represents 10 µm. 
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transfection efficiency was very high, more than 80 %, but nearly every transfected 
cell was dead before the microscopy started. Toxicity of SopB has been described 
before (Aleman et al., 2005). 
 
Figure 34 Transient transfection of different bacteria virulence factors in Hela cells (part I) 
Hela cells were transient transfected with GFP as a control or GFP tagged full length constructs of 
EspT (either from EPEC or from Citerobacter rodentium), or SopB. The actin cytoskeleton was 
stained with red labeled phalloidin, the nucleus with DAPI. The cells were imaged at a 60 x 
resolution and the scale bar represents 10 µm. 
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Only when little amounts of DNA (4 times less than other transfections) were used 
for transfection combined with a rescue treatment by medium exchange two hours 
post transfection, the cells survived long enough to be imaged, but still most of them 
looked troubled. The few transfected and “healthy looking” cells displayed an 
uneven, ragged edge with numerous, long filopodia. In those cells, SopB was 
frequently seen in clusters which concentrate in the nuclear region (Figure 34, lower 
panel), vaguely reminiscent of what was described before.  
 
 
Figure 35 Transient transfection of different bacteria virulence factors in Hela cells (part II) 
Hela cells were transient transfected with GFP tagged full length constructs of IpgB1, IpgB2 or 
SifA. The actin cytoskeleton was stained with red labeled phalloidin, the nucleus with DAPI. The 
cells were imaged at a 60 x resolution and the scale bar represents 10 µm. 
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The ectopic expression of the Shigella virulence factor IpgB1 resulted in an 
ambivalent morphology (Figure 35, upper panel). We observed cells, displaying a 
Rac1-like lamellipodial phenotype, as well as cells producing lots of filopodia, in a 
Cdc42-like fashion. The protein itself was mostly distributed throughout the 
cytoplasm. In contrast, the IpgB2 overexpression resulted in a clear cell morphology. 
We mainly observed small rounded cells with a dense stress fiber network within the 
cell and frequently increased ruffling. This lead in some cases to huge membrane 
ruffles, spanning the whole dorsal surface of the cell. Therefore, RhoA activation via 
IpgB2 does not seem to suppress Rac1 activation, at least not in these cells. IpgB2 
was, always found to be equally distributed throughout the cytoplasm (Figure 35, 
middle). 
Finally, the transient expression of the S.enterica virulence factor SifA resulted in 
wide spread, often rounded cells without polarity. These cells only displayed small or 
even no lamellipodia. Instead, we frequently observed cells producing short 
filopodia. However, these changes were quite subtle for the diverse shape Hela cells 
can show. Again, the protein was mainly equally distributed throughout the 
cytoplasm, with some concentration in the nuclear region (Figure 35, lower panel).   
 
2.4.2 Map provokes a Rac1 like phenotype, RHPN1 induces mild stress fibers 
Before studying putative co-localization of Map and human RHPN1 the effects of 
the single proteins on cell morphology were investigated. For this purpose, Hela cells 
were transfected with GFP labeled Map, RHPN1 full length or RHPN1 domain 
constructs. After fixation of the transfected cells, the actin cytoskeleton was stained 
using red labeled phalloidin and DAPI for the nucleus. 
As shown in Figure 36, Map transfected cells, in contrast to the GFP control, display 
a wide spread, round shape. Furthermore, we observed a dense rim of actin along the 
cell periphery. Both effects are typical for pronounced Rac1 activity. Cdc42 is 
known to induce downstream Rac activation (Nobes et al., 1995). Map itself, is 
distributed throughout the whole cytoplasm. Sometimes, we observed green clusters 
of Map at variable positions. A clear recruitment of Map, for example to actin dense 
lamellipodia or to mitochondria was never seen. This came as a surprise, since Map 
was first described as “Mitochondria associated protein” (Kenny et al., 2000). 
However, in that study an anti Map polyclonal antibody was used and not a GFP 
tagged expression construct.  
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After transfection of human RHPN1 or transfection of the domain construct, we 
made, despite the uniform distribution of the proteins throughout the cytoplasm, a 
different observation. The morphology of these cells was similar to the controls and 
not round. Notably, compared to the control RHPN1 transfected cells display a mild 
increase of stress fibers.  
Map, human RHPN1, human RHPN2 and murine RHPN1 were also ectopically 
expressed in Cos7 cells. In this case, the dot like localization of Map was strongly 
increased. The human RHPN1 was also found in clusters within Cos7 cells, but not 
as prominent as Map was. Only human RHPN2 and mouse RHPN1 were usually 
found equally distributed throughout the cytoplasm.  
Apart from the enhanced expression, the effects on the actin cytoskeleton were not 
that strong in Cos7 cells (data not shown). In brief, Map transfection slightly rounded 
the cells and the RhoA-like effect of RHPN1 expression was present, but milder than 
in case of Hela cells. This raised the question whether the localization of Map and 
rhophilin is random, or if they are targeted to a specific cellular compartment. Since 
it has been reported that recruitment of Map to mitochondria occurs during later 
stages of an EPEC infection (Kenny et al., 2000), we decided to perform a 
co-staining with MitoTracker®, to determine whether Map and RHPN1 locate at 
mitochondria (see 2.4.5).  
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Figure 36 Localization of Map, RHPN1 and its domains after transfection in Hela cells 
Hela cells were transfected with either GFP alone or GFP-Map, -RHPN1, -RHPN1 BRO 
domain, -RHPN1 HR1 domain, -RHPN1 PDZ domain (from top to bottom). Subsequently these 
cells were co stained with red labeled phalloidin and DAPI (blue), to visualize the actin cytoskeleton 
and the nucleus respectively. The cells were imaged at a 63 x resolution and the scale bar represents 
20 µm. 
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2.4.3 Map and RHPN1 can co-localize 
Because of the positive interaction between Map and human RHPN1 in pull down 
assays, we decided to study their subcellular level of co-localization. Therefore 
co-transfections were performed using GFP and RFP labeled versions of RHPN1 and 
Map, respectively.  
After transfection of both constructs into Hela cells, we observed a dramatic change 
in the protein distribution pattern compared to single transfections. In almost every 
cell expressing both proteins, red/green aggregates were observed, these signals 
co-localized perfectly (Figure 37). These aggregates were frequently localized in the 
proximity of the nucleus (A). If not clustered in the cell center, RHPN1-GFP and 
Map-RFP protein aggregates were spread throughout the cell (B). Interestingly, the 
wide spread cell shape, observed after single transfection of Map, was either reduced 
or sometimes even absent in the additional presents of RHPN1. 
In rare cases (about 17 %), transfected cells displayed ruffle formation. In that case 
no aggregates could be found within the cell. Instead, we observed both proteins to 
localize in membrane ruffles near the cell surface (C).  
Finally, we explored the co-localization characteristics of Map together with the GFP 
tagged PDZ domain of RHPN1, which embodies the interaction surface for Map. 
When examining co-transfection of RHPN1-PDZ together with Map, we saw a 
similar distribution pattern as observed for the full length RHPN1-Map 
co-transfections. In other words, both proteins co-localized around the nucleus (D) 
and in rare cases in ruffles near the cell surface (not shown). Noteworthy, the protein 
spots seemed to be smaller and closer to each other (D). In contrast, and as expected, 
the HR1 and BRO domain did not co-localize with Map (not shown). 
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Figure 37 RHPN1 and Map co-localize in Hela cells after co-transfection 
Hela cells were transfected with RFP-Map, either together with GFP-RHPN1 (A-C) or the GFP 
tagged RHPN1 PDZ domain (D). After fixation, cells were imaged at a 63 x resolution. The color 
merge clearly show the strong co-localization of Map and its partner. The scale bar represents 10 µm 
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2.4.4 Co-transfection of small GTPases does not affect the RHPN1-Map 
interaction 
Map and RHPN1 are both able to interact with small GTPases. Map interacts with 
Cdc42 and RHPN1 with RhoA. This rose the question, whether small GTPases are 
able to alter the interaction between Map and RHPN1. To answer this question, Hela 
cells were co-transfected with GFP-RHPN1, RFP-Map and Myc tagged GTPases. It 
was hard to find cells, which were positive for all of the three proteins. In cells, in 
which all three proteins were expressed, no effect of dominant negative Cdc42 or of 
dominant negative RhoA on the RHPN1-Map interaction could be observed and also 
no GTPase recruitment to RHPN1-Map positive sites. In fact, the distribution pattern 
of RHPN1 and Map in this experiment was similar to the distribution found in 
double transfections without the small GTPases. However, the morphology of the 
cells was affected. For example, Cdc42 co-transfection induced or restored the wide 
spread cell shape and sometimes provoked filopodia formation, even though the 
dominant negative variant of Cdc42 was used. In contrast, RhoA co-transfection 
resulted in more contracted cells, only in rare cases wide spread cells were detected. 
 
Figure 38 No influence of GTPases on RHPN1-Map co-localization 
Hela cells were triple-transfected with GFP-RHPN1, RFP-Map and Myc-Cdc42 TN or Myc-RhoA 
TN. Subsequently, cells were fixed and the Myc tag was visualized by using appropriate antibodies. 
Neither the overexpression of Cdc42 TN, nor of RhoA TN alters the localization of RHPN1 and 
Map. The scale bar represents 10 µm 
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2.4.5 MitoTracker staining revealed co-localization between human RHPN1 
and mitochondria 
The localization of Map and human RHPN1 in Hela and Cos7 cells, made us assume 
that mitochondria could be the cellular compartment where these proteins localize. 
Moreover Map has been described earlier to localize to mitochondria (Kenny et al., 
2000). In order to examine whether Map and human RHPN1 are enriched at 
mitochondria, we used MitoTracker® to visualize the mitochondria in transfected 
cells.  
We found the mitochondria as a tubular network, spreading from the nucleus towards 
the cell periphery. In all experiments, independent of the transfected plasmids, this 
tubular network looked similar.  
In case of the GFP control (Figure 39 A), the ectopically expressed protein was 
evenly spread throughout the cytoplasm and no co-localization between 
mitochondria and the proteins was observed. 
When Map, human RHPN1 or its PDZ domain were expressed, we could clearly 
detect the protein accumulations described before. No relevant overlap between 
ectopically expressed Map and mitochondria was observed (Figure 39 B). In case of 
hRHPN1 or PDZ transfected cells the result was different. In these cells we indeed 
could observe co-localizations of the overexpressed proteins with mitochondria, as 
indicated by arrowheads in the respective blow ups of Figure 39 (C+D).  
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The observed overlap was not complete but partial, since there were still some green 
hRHPN1 or PDZ dots without MitoTracker® signal and many mitochondria without 
RHPN1. Upon transfection of human RHPN2 (Figure 39 E) and mouse RHPN1 
 
Figure 39 Map did not localize to mitochondria but human RHPN1 
Cos7 cells were transfected with the indicated GFP constructs and treated with MitoTracker® 
according to the manufactures manual. Microscopic analysis revealed at least partial localizations of 
hRHPN1 and hRHPN1-PDZ to mitochondria, as indicated by arrowheads. The scale bar represents 
10 µm. 
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(Figure 39 F), no localization of those proteins at mitochondria was observed. 
Together, it will require further experiments with exchanged colors to pinpoint where 
and when RHPN1 and mitochondria come together. 
 
2.5 Infection assay 
In order to determine whether and how RHPN1 is involved in EPEC infection, we 
performed infection assays. To do so, Cos7 cells were transfected with GFP tagged 
human RHPN1, human RHPN2, mouse RHPN1, Map or the PDZ domain of human 
RHPN1. Next, the transfected cells were infected with the EPEC strain E2348/69, 
washed and fixed at different time points (30 min, 60 min and 180 min post 
infection). The cells were stained with DAPI to detect the bacteria attached to the cell 
surface and phalloidin to visualize the actin cytoskeleton, in particular the actin rich 
pedestal below the bacteria. At 30 min post infection, no bacteria were found to be 
attached to the cell surface, therefore only images after 60 and 180 min are depicted 
here (Figure 40). 
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In general, 1 h after infection, we found 3 to 10 bacteria, or clusters of bacteria 
attached to the cell surface. This number was consistent, independent from the 
transfected plasmid. Two hours later, although the cells were washed every hour to 
reduce the amount of bacteria, the number of bacteria attached to single cells 
increased to very high numbers. For this reason, only the images of the 1 hour time 
point were used for statistical analysis. The bacteria attached to each transfected cell 
were counted, as well as the number of corresponding pedestals (Figure 41), the 
results of this statistics will be analyzed together with the microscopy images in the 
following paragraph.  
 
The negative control, Cos7 cells transfected with GFP alone (Figure 40 A) revealed a 
normal cell shape and in addition some pedestals after 1 h and many more after 3 h. 
Out of 48 analyzed images, we found 220 bacteria or bacteria clusters attached to the 
transfected cells. Only 141 of them were attached to pedestals. Consequently, 64 % 
of the bacteria attached to GFP positive cells provoked the formation of pedestals 
within one hour of infection (Figure 41). Interestingly, at the 3 h time point, the 
 
Figure 40 Pedestal formation beneath attached bacteria at different time points after infection  
Cos7 cells, transfected as named on the right side of each set of images, were infected with EPEC 
and subsequently fixed after 1 h or 3 h infection. Later the cells were stained with red labeled 
phalloidin in order to visualize the actin cytoskeleton and stained with DAPI, to highlight the 
bacteria which are attached to the cell surface. Arrowheads indicate infection sides. The scale bars 
represent always 10 µm. 
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pedestals are smaller and less proper in shape, compared to after 1 h. Furthermore it 
seemed that the amount of pedestal positive bacteria had decreased. This may be 
explained by the increased numbers, leading to actin consumption and cell stress. 
In case of Map expression (Figure 40 B), the amount of pedestal positive bacteria, 
1 h after infection, in 46 analyzed images was increased by approximately 14 % to 
78 % compared to the GFP control (Figure 41). After 3 h the pedestals are still equal 
in shape and size and it seems, as if every bacterium has its own pedestal. The 
number of pedestals built up below these attached bacteria, however, was not 
statistically evaluated. Thus, the presents of Map may reduce cell stress and/or 
mobilize actin to help establish the infection. 
In contrast, when expressing human RHPN1 the number of pedestal positive bacteria 
1 h after infection was decreased by 12 % down to 52 % (Figure 41). Two hours 
later, although the number of bacteria was apparently similar to that in the other 
experiments, it was hard to find any pedestals at all (Figure 40 C). Instead the 
bacteria showed up in the GFP channel (Figure 40 C, lower panel). We saw this 
 
Figure 41 Pedestal formation efficiency differs with respect to the transfected plasmid 
The images taken from the infection assays at time point 1 h were analyzed on the one hand for the 
number of bacteria, attached to transfected cells and on the other hand for the corresponding 
pedestals beneath each bacterium. Clusters of two or more bacteria were counted as one. The same is 
true for the belonging pedestals, even though, if not every bacterium within a cluster had its own 
pedestal. 
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phenomenon in about 50 % of all transfected cells. The GFP signal perfectly 
co-localized with the bacteria in the DAPI channel, indicating the recruitment of 
RHPN1 to the infection side. However, the complete absence of F-actin made it 
impossible to judge on the exact status of infection. The GFP signal also did not 
accumulate beneath the bacteria in a characteristic pattern, making it possible that we 
look at bacterial invasion and subsequent recruitment of the GFP labeled protein to 
internalized bacteria. To address the possibility of bacterial internalization, we 
performed a gentamycin protection assay (see 2.6). With this assay, the number of 
intracellular living bacteria can be exactly determined. 
Human RHPN2 also reduces pedestal formation after 1 h, similar to hRHPN1. 
However, 3 h post infection pedestals were still present, albeit impaired, and the GFP 
signal had accumulated close to the bacteria but did not label them like hRHPN1 did 
(Figure 40 D). The pedestal formation efficiency at time point 1 h was lower (50 %) 
as compared to control (Figure 41).  
In mouse RHPN1 expressing cells the portion of bacteria which were able to provoke 
pedestals (60 %), was almost at control levels (Figure 41). Also after 3 h of infection, 
the pedestal formation seemed to be unaffected (Figure 40 E). 
Finally we tested the influence of the human RHPN1 PDZ domain under infectious 
conditions. The result was virtually identical to the GFP control  
 
2.6 Gentamycin protection assay  
In order to examine the potentially increased invasiveness of EPEC in human 
RHPN1 transfected cells (Figure 40 C, lower panel), we decided to perform a 
gentamycin protection assay. Cos7 cells were transfected with GFP or with one of 
the three GFP RHPN constructs. Next, these cells were either treated with EPEC, or 
as a negative control with E.coli C600. After 3 hours, all extracellular bacteria were 
killed by applying the non cell permeable antibiotic gentamycin. Subsequently the 
cells were lysed and plated in appropriate dilutions on LB-agar plates. The next day, 
the colonies were counted. Each colony represents one living intracellular bacterium. 
The results of three independent sets of experiments were grouped and analyzed 
(Figure 42). 
In case of E.coli C600, usually around 300 colonies were found. The GFP and the 
human RHPN1 attempt resulted both in 345 colonies. The number of colonies gained 
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from cells which expressed the other two rhophilins was not statistically significantly 
different from the control.  
In case of EPEC, there was clearly a higher number of colonies, on average 100 
times more colonies compared to the E.coli control. In this experiment, the highest 
number of colonies was derived from lysates of cells transfected with GFP alone. 
The transfection of human RHPN1 did not result in a statistically significant change 
of colony numbers. 
 
We next reasoned that the bacteria labeled with GFP-RHPN1 could potentially be 
intracellular but dead and therefore absent from the gentamycin protection assay, that 
evaluates only living bacteria. Therefore, we employed an additional approach to 
specifically stain intra- versus extracellular bacteria. In this experiment we aimed to 
find out if the green rods, observed in cells transfected with human RHPN1, are 
internalized dead bacteria or a result of protein recruitment beneath extracellular 
bacteria. To do so, an anti E.coli antibody was used. This antibody from Novus 
Biologicals specifically recognizes the J5 lipopolysaccharide (LPS) in the bacterial 
cell wall of all E.coli, such as C600 or EPEC. 
 
Figure 42 The gentamycin protection assay revealed no rhophilin mediated EPEC invasion 
The numbers from counting the colonies grown from bacteria which survived the gentamycin show, 
that neither human RHPN1 transfection, nor any other tested rhophilin result in an increased 
invasiveness of E.coli (blue) or EPEC (red). The small variations are without statistical relevance.  
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We repeated the infection assay described in 2.5 using Cos7 cells transfected with 
human RHPN1 or mouse RHPN1. Three hours after EPEC infection, the cells were 
fixed and stained with the anti LPS antibody without any permeabilization step. 
Additionally a DAPI staining was performed. The idea was that the LPS antibody 
should not be able to permeate the cell and thus, only stain bacteria on the cell 
surface, while DAPI stains also internalized bacteria. In other words, internalized 
bacteria should only be stained in blue. When analyzing the fixed cells by fluorescent 
microscopy, we observed after transfection of GFP, no rod like structures and only 
small numbers of weak LPS positive structures (Figure 43 A). However, upon 
transfection of hRHPN1 again in about 50 % of all hRHPN1-GFP positive cells, we 
noticed rod shaped structures in the GFP channel (Figure 43 B+C). Only very 
sporadically, single co-localizations with blue labeled bacteria in absence of red were 
observed (Figure 43 C). More frequently we saw deformed, weak LPS positive 
structures, which co-localizes with green and blue accumulations (Figure 43 B). In 
case of mouse RHPN1 transfected cells, sometimes also protein accumulations were 
observed in the green channel. However, these accumulations were, in contrast to 
human RHPN1 transfected cells, not co-localized with DAPI or LPS signals but 
rather diffuse (Figure 43 D).  
The weak LPS positive structures could be remnants of phagocytosed bacteria. Also 
the experimental protocol may lead to staining via small amounts of the anti LPS 
antibody, which were able to pass the membrane. Further experiments are necessary 
to unambiguously clarify this. Taken together, the gentamycin result and the high 
amount of weak LPS positive structures within cells upon human RHPN1 
transfection allow to speculate that RHPN1 induces phagocytosis of EPEC probably 
throughout autophagy of plasma membrane. At the time point of cell fixation, the 
bacteria are most likely already dead and therefore cannot count positive in the 
gentamycin protection assay. 
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Figure 43 Staining of bacteria with an anti LPS antibody after infection assay 
Cos7 cells transfected with either GFP alone, human RHPN1-GFP or mouse RHPN1-GFP were 
infected for 3 h with EPEC. Subsequently, the cells were fixed and stained with DAPI and an anti 
LPS antibody without performing a permeabilization step. Arrowheads indicate structures, 
observable in the red and blue channel, while asterisks highlight structures visible only in the green 
and blue channel. The scale bar represents 10 µm. 
 
 
Results 64 
 
2.7 RHPN1 CHMP4b interaction 
The potential autophagy described in the previous chapter may involve the 
ESCRT III complex, which is known to participate in different membrane associated 
processes like bending, or fission. Although we were not able to show an interaction 
between the ESCRT III subunit CHMP4b and human RHPN1 in pull down assays, 
we tested the abcam® antibody for immunofluorescence microscopy (Figure 44). 
No matter if RHPN1 was expressed alone, or together with Map in Hela cells, we 
were not able to observe a recruitment of CHMP4b towards RHPN1 or RHPN1/Map 
positive structures. 
 
 
 
 
 
Figure 44 No recruitment of CHMP4b towards RHPN1 and/or Map positive structures 
In (A) Hela cells were transfected with GFP tagged human RHPN1 and subsequently stained with 
abcam® anti CHMP4b antibody. In (B), the cells were additionally co-transfected with Myc tagged 
Map. Arrowheads indicate spots of protein accumulations. The scale bars represent 10 µm. 
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3 Discussion 
The aim of this work was to identify so far unknown interaction partners of bacterial 
virulence factors on the host side. To get an idea where we had to start searching, we 
performed a large Y2H screen which comprised several variants of 10 bacterial 
proteins as baits and a genome wide human cDNA derived protein collection as 
preys. This screen resulted in over 150 hits, some of them, being more and some of 
them, being less likely. This was estimated based on their behavior in more than 100 
previous screens performed by our cooperation partners at the DKFZ in Heidelberg.  
Out of the pool of likely protein interactions, which was still numerous, we have 
chosen those involved in processes that might play a role in pathogenicity and as 
GTPases, their interactors and proteins involved in trafficking or migration. 
Furthermore we decided to follow some additional hints since they seemed 
promising.  
To verify the selected Y2H interactions, we first utilized biochemical methods. To do 
so, we purified recombinant virulence factors, as well as their putative interactors 
from bacteria and immobilized them to appropriate sepharose beads. Subsequently 
these proteins were used in pull down experiments against lysates of mammalian 
cells ectopically expressing the putative partner. All pull downs were performed until 
a statistical relevant conclusion was possible, but at least three times. The 
experiments always included suitable negative and if available also positive controls. 
In case that a pull down was repeatedly negative, we put the respective hit aside and 
focused on the next. We cannot exclude that these hits are relevant since the negative 
result can come from experimental conditions. However, we decided to test the large 
number of hits in a straight forward standard procedure, keeping potential overseen 
interactions in mind. If a pull down experiment was convincingly positive, at the best 
also in vice versa approaches, we strengthened the result by further methods, namely 
co-immunoprecipitation, and/or immunofluorescence microscopy.  
Finally we tested our findings in infection assays, trying to create a model that puts 
our results into the whole infection context and explain the biological relevance of 
this process. 
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3.1 EspT does not interact with Arf6 
The first interaction, which we tested was the one between EspT and Arf6. We 
considered this pair as potential relevant because Arf6, as a small GTPase involved 
in reorganization of the actin cytoskeleton and in endocytosis (Donaldson, 2003, 
D'Souza-Schorey et al., 2006), is very likely active during infection. Although the 
formal prove of an interaction was still missing, it has been reported that the small 
Rho GTPases Rac1 and Cdc42 were activated by EspT (Bulgin et al., 2009b, 
Orchard et al., 2012a). Thus it was attractive to test if EspT is a direct activator of 
Rac1 and/or Cdc42 or indirect, for instance via Arf6. A direct link between Rac and 
Arf6 activation has been described before (Radhakrishna et al., 1999, D'Souza-
Schorey et al., 1997).  
When inspecting the pull down assays between EspT and different versions of Arf6 
(Figure 16), it became obvious that no interaction between both proteins was 
detected. In contrast, strong interactions were observed between recombinant EspT 
and the constitutive active (CA) versions of Rac1 and Cdc42, also in the vice versa 
approach using recombinant Rac1 and Cdc42 both activated GTP-loaded GTPases 
interacted with EspT (Figure 17). As a member of the WxxxE family with predicted 
GEF activity (Ohlson et al., 2008), we had expected that EspT interacts with the 
dominant negative GDP-loaded versions. One hand this showed that our 
experimental procedure is working, on the other hand they raised different new 
questions. First, if EspT interacts with GTP loaded Rac1 and Cdc42, how is the 
published GTPase activation accomplished? This is an important question, since also 
in our hands, EspT overexpression resulted in a typical Rac1/Cdc42 hyper activation 
phenotype of the cell morphology (Figure 34). Second, if EspT possesses GEF 
activity and neither the tested Rho GTPases nor Arf6 is the substrate, what is the real 
target? Finally, the binding to CA GTPases implicates a function as a downstream 
effector of Cdc42 and Rac1, leading to the question in which pathway EspT might be 
integrated. Therefore, in the future we will revisit EspT using other assay. Also a 
crystal structure, that in the case of IpgB2 and RhoA clearly revealed the 
GEF-activity, may teach us a lot about EspT/Rac1 or EspT/Cdc42. 
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3.2 SopB does not interact with the V-ATPase subunit ATP6V1E1 
In contrast to the other virulence factors mentioned in this thesis, SopB belongs to a 
different protein class. SopB is not a member of the WxxxE protein family and is not 
a bacterial GEF. Yet, it is one of the Salmonella type III secreted virulence factors 
(Zhou et al., 2001) and plays an important role in invasiveness and later in infection 
(Hänisch et al., 2011, Roppenser et al., 2012). The SopB protein comprises two 
known functions. First a phosphoinositide phosphatase activity (residues 357-561) 
(Norris et al., 1998) and second a GTPase binding capacity (residues 117-168) 
(Rodriguez-Escudero et al., 2011), which are both involved in the stimulation of 
cytoskeletal rearrangements and perpetuation of the SCV. 
In our Y2H, SopB interacted with the ATP6V1E1 subunit of the V-ATPase. This 
ATPase is a evolutionary highly conserved machinery among eukaryotes and play an 
essential role in acidification of cellular organelles by pumping protons across 
membranes (Perez-Sayans et al., 2012). 
Upon Salmonella invasion, several host proteins are targeted to the SCV membrane, 
among them the V-ATPase (Martinez-Lorenzo et al., 2001). Having a look at other 
pathogenic bacteria, for example Streptococcus pyogenes or Mycobacterium 
tuberculosis, one can see that there are cases, in which the ATPase is a targeted to 
prevent acidification of the phagosome (Nordenfelt et al., 2012, Wong et al., 2011b). 
Due to its adaptive acid tolerance (Garcia-del Portillo et al., 1993a) Salmonella is not 
fully dependent on prevention of acidification of the SCV, however an interference 
with the ATPase could still be advantageous. 
Our pull down assay results of SopB and different small GTPases of the Rho family, 
revealed a strong interaction with dominant negative and constitutive active Cdc42 
(Figure 19). This fitted perfectly to the literature (Rodriguez-Escudero et al., 2011) 
and confirmed that our recombinant SopB is, at least in part, properly folded. The 
interaction to ATP6V1E1 however, was in three independent experiments always 
negative.  
Besides the possibility that there really is no interaction between the V-ATPase 
subunit and SopB, we cannot exclude technical reasons for this, since we have no 
control on the folding of the PiPase region. Moreover the interaction may require 
membrane or additional proteins. Finally the GFP tag may have blocked an 
interaction and recloning may solve this problem. We currently plan different 
additional approaches to clarify this issue. 
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3.3 IpgB2 interacts with BBS4 
IpgB1 and IpgB2 are two related Shigella virulence factors. They are further 
members of the WxxxE family and should stimulate the formation of lamellipodia, 
ruffles and stress fibers in the host cell upon transfection, respectively (Alto et al., 
2006, Klink et al., 2010). Upon transient transfection of IpgB1 into Hela cells, we 
observed a diverse morphology. In different attempts, we saw IpgB1 positive cells, 
displaying a Rac1- or Cdc42-like phenotype. Sometimes also a mixture of both 
phenotypes was seen (Figure 35). This fits to the report, that IpgB1 is able to 
accelerate the Rac1 activation 32-fold and the Cdc42 activation at least 6-fold 
(Huang et al., 2009), exerting GEF activity on those GTPases.  
In our hands however, we were not able to reproduce the interaction of IpgB1 and 
Rac1 or Cdc42 in pull down experiments (Figure 21), which were described by 
Huang and colleagues. Since we had no hit in the Y2H and our pull down assays 
between Rac1 or Cdc42 and IpgB1 were negative, too, it might be possible that the 
interaction is weak and transient in an “kiss and run” style. Maybe it would have 
been possible to finally reproduce the interaction, by the preparation of new 
recombinant IpgB1 or by changes in our experimental procedure. But since the Y2H 
screen has provided no potential interaction partners, we decided continue on IpgB2. 
The ectopic expression of IpgB2 was reported to provoke a RhoA like stress fiber 
response in HEK293A cells (Alto et al., 2006, Klink et al., 2010). In our 
experiments, we used Hela and Cos7 cells to analyze the results of transient 
transfections. We frequently observed rounded cells, often lined with lamellipodia. 
Cell surface spanning ruffles were also found usually. However, the RhoA effect 
described by Alto and colleagues was not that strong in these cell types. Indeed, our 
cells were filled with a dense stress fiber network, but the single fibers were rather 
thin (Figure 35). One explanation for the difference between the observed 
cytoskeletal phenotypes could be the usage of different cell types.  
For IpgB2 it has been shown on crystal structure level that the virulence factor 
specifically interacts with GDP-loaded RhoA and catalyses the nucleotide exchange 
(Klink et al., 2010). The authors also showed in the same article, that IpgB2 
accelerates the exchange ~10
4
-fold compared to the intrinsic rate. This is more than 
one order of magnitude above the efficiency of mammalian GEFs of RhoA.  
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In our pull down experiments immobilized IpgB2 clearly interacts with dominant 
negative Myc-tagged RhoA (Figure 22 A). With this successful positive control we 
started to analyze the potential interactions with BBS4 and TRAPPC6A.  
BBS4 is one of eight proteins, forming the core of a multiprotein complex called 
BBSome, which is located to non-membranous centriolar satellites and to the 
primary cilium (Nachury et al., 2007, Loktev et al., 2008). The 52 kDa protein was 
first described as one of 12 potential mutants, causing the Bardet-Biedl syndrome, a 
ciliopathic human genetic disorder (Mykytyn et al., 2001).  
The second protein TRAPPC6A is one, of the six component TRAPP I complex. 
This complex is involved in vesicular transport at the endoplasmic reticulum (Sacher 
et al., 2008).  
In our pull down assays using immobilized IpgB2, we were not able to validate the 
interaction with TRPPC6A (Figure 22 A). In case of BBS4 we could adjust the 
experimental conditions, and detect a clear and reproducible interaction between 
IpgB2 and BBS4 (Figure 22 B). 
This experiment demonstrates perfectly, how important it is to modify the 
experimental setup when an interaction appears negative in a first attempt. 
Subcloning BBS4 into a protein expression vector, was crucial for showing the 
IpgB2 BBS4 interaction. 
Since nothing is known about an interaction between IpgB2 or any other virulence 
factor and BBS4, the question rises, how does Shigella benefit from targeting BBS4? 
We already know, that BBS4 as part of the BBSome localizes at the primary cilium. 
These organelles are found in a broad range of vertebrate cells and are involved in 
many signaling events, like the wnt signaling or the hedgehog signaling pathway 
(Gerdes et al., 2009). Furthermore, it was reported that depletion of BBS4 in mice, 
does not affect the formation cilia (Mykytyn et al., 2004), but might play a role in the 
intraflagellar transport (IFT) (Wei et al., 2012). Primary cilia are typical for the G0 
phase and are disassembled in all other phases of the cell cycle (Kim et al., 2011). 
Additionally, BBS4 is a component of centriolar satellites (Loktev et al., 2008). 
These structures are required for primary cilium formation but may also serve 
physical checkpoint function since they contain CDK1 and cylinB2 (Spalluto et al., 
2013). 
But why should IpgB2 target BBS4? One potential connection is the small GTPase 
RhoA, which was found to be substrate to IpgB2 (Klink et al., 2010), involved in 
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cilia formation (Pan et al., 2007) and significantly increased in BBS4 knockout cells 
(Hernandez-Hernandez et al., 2013). RhoA possibly connects both proteins. 
A first experiment to test the influence of IpgB2 in the cilia context might be 
co-localization studies between the virulence factor, BBS4 and cilia, to see if BBS4 
recruitment or cilia formation is altered or even impaired. A current master thesis 
(Eric Meinhardt) is following this interaction. 
 
3.4 The SifA – Rab9 interaction 
The Salmonella virulence factors SifA and SifB were among the first described 
WxxxE family members (Alto et al., 2006). SifA seems to be absolutely necessary 
for the formation of Salmonella induced filaments (Stein et al., 1996). It is also 
known that SifA binds to a host protein termed SifA kinesin interacting protein 
(SKIP), which is capable to connect to the plus-end directed microtubule motor 
kinesin. Disturbing this interaction results in impaired tubulation (Boucrot et al., 
2005). Together with a second effector protein, SseJ, SifA also contributes in the 
maintenance of the phagosome (Ruiz-Albert et al., 2002). In contrast to other WxxxE 
proteins, SifA and SifB do not appear to affect actin dynamics (Bulgin et al., 2010). 
This largely agrees with our microscopic SifA overexpression studies. We neither 
observed large lamellipodia or massive filopodia formation, nor did we observe an 
increase in stress fibers or adhesions. Only the cell shape was slightly altered 
compared with control transfected cells, as it was more rounded and appeared more 
widely spread (Figure 35). Up to now there is only one report by Ohlson and 
colleagues, postulating that SifA may function as a GEF of RhoA. However, they 
were not able to show GEF activity for purified SifA and the pull down experiments, 
(with an overexposed load-control, no supernatant-control and a weak signal in the 
pull down lane), was not very convincing (Ohlson et al., 2008). Consequently, in our 
experimental setup, which is quite stringent, we were not able to detect an interaction 
with RhoA (Figure 24).  
Alternative to Rho-GTPases we followed hints that SifA might interact with Rab 
GTPases. In mammalian cells Rab GTPases are involved in multiple vesicle 
trafficking pathways. Here they organize transport and recycling by marking 
different vesicle populations (Zerial et al., 2001). In the context of Salmonella 
infection, Rab4 and Rab5 were reported to be recruited to the early phagosome in the 
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first 60 min after infection, indicative of interactions with early endosomes (Smith et 
al., 2005). Subsequently, Rab7 and Rab9, late endosomal markers, are recruited to 
the SCV and were reported to be essential for the Sif formation (Smith et al., 2007, 
Brumell et al., 2007). In this context, it is remarkable that in cells SKIP interacts with 
Rab9 and this interaction is disturbed by SifA (Jackson et al., 2008). 
In our study, we were able to detect a direct interaction between SifA and Rab9a in 
pull down experiments. Additionally, a weak interaction with Rab11a was observed, 
however, not consistent enough and thus requires further experiments. Other Rab 
GTPases, like Rab4a, Rab5a and Rab7a displayed no direct interactions under these 
conditions (Figure 25). 
In contrast to SifA, only little is known about SifB. SifB is translocated via the 
second Salmonella T3SS and localizes to the SCV, but depletion of the effector 
protein has no noticeable effect on the SCV integrity or Sif formation (Freeman et 
al., 2003). On these grounds, the authors speculate about a function of SifB in later 
stages, or special situations of the infection. Interestingly, from our Y2H screen we 
have a potential interaction with the Rap-GTPase interactor RADIL that is in play in 
cell adhesion. This hit is currently followed in an independent work together with 
two other potential hits. 
For SifB in our Y2H screen the most significant hit was Cdc42. Thus, we tested the 
virulence factor against a selection of Rho- and Rab GTPases in parallel to SifA. 
However, we never got a positive interaction (Figure 24 and Figure 25). At this point 
we have to consider that for the Y2H screen with SifB and in the biochemical 
experiments only a truncated version, lacking the first 98 aa, was used. Revisiting 
SifB interactions with the full length protein is planned for the future. 
 
3.5 The interaction between Map and human RHPN1 
The virulence factor Map, present in the A/E group of pathogenic bacteria, is also a 
member of the WxxxE effector protein family (Alto et al., 2006) and was reported to 
function as a Cdc42 GEF mimic (Huang et al., 2009). Upon intimate contact between 
EPEC and the host cell, Map is translocated via the T3SS and targets Cdc42 in order 
to remodel the GTPase signaling (Huang et al., 2009, Kenny et al., 2002, Alto et al., 
2006). To accomplish the alteration of Cdc42 signaling, the interaction with a second 
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host protein, the EBP50, via the Map PDZ-domain binding motif, is mandatory 
(Berger et al., 2009, Simpson et al., 2006).  
Targeting Cdc42 by Map results in the formation of Cdc42 dependent filopodia at the 
infection side (Berger et al., 2009, Kenny et al., 2002, Orchard et al., 2012b) and 
also ectopic Map expression provokes filopodia formation (Bulgin et al., 2010). In 
our experiments we observed filopodia formation, too. More frequently, however, we 
recognized a wide spread cell shape, with protruding lamellipodia (Figure 36). This 
effect is most likely due to Cdc42 induced Rac1 activation, because of signaling 
crosstalk between these GTPases (Hall, 1998).  
The two most significant hits from the Y2H screen for Map were the EBP50 paralog 
NHERF2 and rhophilin1 (RHPN1). First, we tested our recombinant Map in pull 
down assays against Cdc42 and were able to reproduce this direct interaction (Figure 
27). Subsequently, we started to examine the predicted interaction partner human 
RHPN1.  
The human RHPN1 was identified as an interactor of GTP bound RhoA (Watanabe 
et al., 1996). Later, Peck and colleagues characterized a structurally related protein 
(40 % aa similarity), RHPN2, in humans. Both proteins are thought to act as 
scaffolds downstream of RhoA. Contrary to Watanabe, Peck reported RhoA binding 
in the GTP as well as in the GDP bound conformation (Peck et al., 2002). In our pull 
down assays, we were able to support Peck by detecting interactions of RHPN1 
together with immobilized CA and DN RhoA. Moreover we observed strong 
interactions with CA Rac1 as well as weak interactions between RHPN1 and DN 
Rac1 or CA Cdc42 (Figure 28 A+B). Unfortunately, we were not able to detect any 
interactions in the vise versa approach, using immobilized RHPN1 (Figure 28 C). 
Possibly the GST tag used in these experiments somehow blocks the N-terminal HR1 
domain and prevents an interaction with the GTPases. Allternatively, full length 
rhophilin might not be properly folded. Therefore we will repeat these experiments 
with GST-HR1. To address this point, recloning is considered. To test, if RhoB 
might be a further candidate to interact with human RHPN1, we cloned WT and CA 
RhoB. Interestingly RhoB binding to human RHPN2 was already described (Peck et 
al., 2002). 
The ectopic expression of RHPN2 was described to cause a loss of stress fibers, 
while RHPN1 expression had no noticeable effect on the cytoskeleton (Peck et al., 
2002). Here we also observed no effect of RHPN1 upon transfection (Figure 36) and 
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indeed, the expression of human RHPN2 resulted in a decrease of stress fibers, 
however, not in a total loss.  
Both proteins share the same domain composition: A N-terminal HR1 domain, which 
mediates the RhoA binding, a C-terminal PDZ domain, known to be involved in the 
formation of protein complexes (Jelen et al., 2003) and finally a central Bro1 
domain, named after its homolog from budding yeast (Nickas et al., 1996). The PDZ 
domain was promising, since Map contains a PDZ binding motive, too (Alto et al., 
2006). In pull down assay we were able to prove a direct interaction between Map 
and human RHPN1. The specificity of this interaction was emphasized by the fact 
that Map was shown to interact with mouse RHPN1, but not with human RHPN2 
(Figure 29). Subsequently, we mapped the interaction surface. To do so, we designed 
constructs of the human RHPN1 domains HR1, PDZ and Bro1 and utilized them in 
pull down assays to probe for Map and vice versa. Western blot analysis revealed a 
clear interaction between the recombinant protein and the PDZ domain (Figure 30 
A). Surprisingly, when running pull down assays with other PDZ domains, including 
human RHPN2 and mouse RHPN1 PDZ, we detected no interactions, although the 
full length mouse RHPN1 interacted with Map (Figure 30 B). The reasons for this 
inconsistency may be found in the design of the PDZ construct, although 
bioinformatical protein domain predictions were performed before. Another problem 
could be the position of the GFP tag, a change from the N- to the C-terminus might 
lead to different results.  
To support our results concerning the Map human RHPN1 interaction, we decided to 
perform co-IPs (Figure 32). We co-transfected GFP tagged RHPN1 and Myc tagged 
Map in B16 cells and performed the precipitation by using anti GFP or anti Myc 
antibodies. We used pre-conjugated anti Myc-bead material, which lead to repeatedly 
positive results. Since Myc tagged Map migrates at the same height as the antibody 
light chain, resulting in cross reactions which made it hard to discriminate between 
Map and artificial signal. To address this problem, one could think about several 
approaches. For example the use of a secondary antibody like TrueBlot® from 
Rockland Immunochemicals, specific against native antibodies. Furthermore a 
change to native conditions may prevent antibody segregation. Finally it should be 
considered to (ex)change the protein tags which would result in a bigger Map 
protein, not masked by cross reactions. Nonetheless, we are convinced that our 
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interaction data unambiguously demonstrate a specific interaction between the 
PDZ-domain of rhophilin1 and bacterial Map. 
Next, we performed co-localization studies between Map and RHPN1. These (Figure 
37) revealed an almost complete congruency of both proteins. In most of the cases 
small globular structures were observed, either close to the nucleus or distributed 
throughout the whole cytoplasm. After single transfection of human RHPN1 or Map, 
those dots were observed, too, but by far not that numerous. This result made us 
speculating about the compartment where both proteins are recruited to. Our first 
thought was mitochondria, since Map was reported to locate at mitochondria during 
late stages of EPEC infection (Kenny et al., 2000). Therefore we performed 
MitoTracker® staining in RHPN or Map transfected cells (Figure 39). Interestingly 
the mitochondria staining revealed no co-localization with Map, suggesting, Map is 
not dominantly targeted to these organelles but probably at some point during 
infection, where further bacterial virulence factors might contribute to mitochondria 
targeting. Unfortunately, the simultaneous use of co-transfections and MitoTracker® 
did not work, because the combination of our Myc antibody together with the blue 
labeled secondary antibody produced such a high background signal that it was 
impossible to discriminate between transfected and untransfected cells. Unexpected 
to us, however, we observed a partial localization of human RHPN1 or its PDZ 
domain to mitochondria. The other tested RHPNs showed no correlation with 
MitoTracker®. The other putative compartment where RHPN1 and Map could meet 
are vesicles. We hypothesized this based on the dot like structure and, on the other 
hand, because it was reported that human RHPN2 is found at late endosomes (Steuve 
et al., 2006), although we scarcely observed clear localizations. Beside the full length 
proteins, already the RHPN1 PDZ domain is sufficient to induce a strong recruitment 
of Map. In this case, however no small dots were seen, but a ring like structure 
surrounding the nucleus, suggesting the cell endomembrane system such as the 
endoplasmic reticulum as interaction surface instead of mitochondria. 
The fact, that RHPN1 contains a Bro1 domain lead us to the theory that RHPN1 
might also interact with the endosomal sorting complex (ESCRT) required for 
transport. The ESCRT machinery was first described in yeast, for its crucial role in 
sorting membrane proteins into lysosome like vacuoles. In humans more than 20 
proteins interact to form three different complexes (ESCRT I-III). They fulfill 
functions in endosomal sorting of ubiquitinated receptors and mediate membrane 
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curvature and fission processes, such as cytokinetic abscission or in the biogenesis of 
multivesicular bodies (MVB) (Rusten et al., 2012, Jouvenet, 2012). In yeast the Bro1 
protein was described to interact directly with the ESCRT component Snf7 and 
function with, or downstream of ESCRT III in the MVB pathway (Odorizzi et al., 
2003). In mammals the close related Bro homolog is called Alix (Missotten et al., 
1999, Vito et al., 1999). We therefore suggest that Map targets RHPN1 to subsequent 
recruit the ESCRT III complex towards the infection side. Hijacking of the ESCRT 
machinery has been reported to be important for the budding of different enveloped 
viruses. The human parainfluenza virus HPIV1, a prominent respiratory pathogen, 
encodes a set of accessory C proteins, which are involved in the regulation of the 
virus replication rate, suppression of the IFN response and suppression of apoptosis. 
Furthermore, these proteins bind to Alix, a Bro1 domain containing protein, capable 
of recruiting the ESCRT subunit CHMP4b (Boonyaratanakornkit et al., 2013). The 
authors suggest, that by targeting CHMP4b via Alix, the C proteins are recruited to a 
specific side at intracellular membranes, where they can promote virus budding. 
Studies on the retrovirus HIV and ESCRT III have an even longer history and the 
first connection between virus budding and ESCRT machinery was drawn in 2003. A 
few molecules of the virus protein Gag attach at one point of the membrane and 
accumulate more and more Gag protein. Simultaneous Alix is recruited towards the 
cytosolic side of Gag and the viral envelop starts to form. When the envelop is 
almost completed, ESCRT and the associated protein Vsp4 are recruited and fission 
take place. The whole procedure takes only 10 min (Strack et al., 2003, Pires et al., 
2009, Morita et al., 2011, Jouvenet, 2012). Finally, in another study the positive 
effect of Alix on virus was lead back to its Bro-domain (Popov et al., 2009). More 
importantly, the Bro domain of Alix could be replaced by that of rhophilin with the 
same efficiency (Popov et al., 2009). From this we delineate that RHPN1 may serve 
as alternative ESCRT adapter under specific conditions. Interestingly ESCRT is not 
only associated with membrane sorting but also with autophagy (Rusten et al., 2009). 
Since autophagy is an important defense mechanism against pathogens (Mostowy et 
al., 2011) this may be the cause of recruitment. 
To see if there is any connection between human RHPN1 and ESCRT, we tested two 
different antibodies against CHMP4b, the ESCRT III subunit that is bound by the 
Bro1 domain containing protein Alix. On the one hand, we tried to perform pull 
down assay with endogenous CHMP4b against immobilized human RHPN1. 
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Unfortunately, both antibodies we used produced so many cross reactions in the 
western blot detection, that we were not able to identify CHMP4b (Figure 31). On 
the other hand, we used one of the antibodies in immunofluorescence microscopy of 
Hela cells transfected with human RHPN1. In this case the antibody performed well, 
but no co-localization was observed (Figure 44). Although we failed to show an 
interaction between RHPN1 and the ESCRT machinery, it still may exist. It could 
possibly be shown for example by the use of ectopic expressed CHMP4b instead of 
the endogenous. Alternatively, RHPN1 might only assemble with ESCRT-subunits 
under special conditions such as during bacterial attachment or during escape from 
autophagy. Further studies will shed light on this question. In this context, it is 
tempting to speculate on the potentially internalized dead bacteria observed after 
ectopic RHPN1 expression. However, more data are needed to confirm such a 
connection. 
Together, the current thesis has provided evidence for several interactions of 
virulence factors with host cell proteins. The interaction between Map and human 
RHPN1 was further characterized. We mapped the interaction surface between both 
proteins and tried to approximate a physiologic function of RHPN1 in cells and of 
this interaction during infection. 
To do so, we turned to run EPEC infection assays. In a first experiment we checked 
if the ectopic expression of any RHPN somehow affects the formation of pedestals at 
the infection site. Analysis of pedestal formation revealed that indeed the 
transfections of Map contributed positively to pedestal formation. Human RHPN1 
and RHPN2 expression showed a repressive influence (Figure 41). The Map 
dependent growth of pedestals suggests that ectopically expressed Map amplifies the 
function of the endogenous protein which was translocated via the EPEC T3SS. The 
interpretation of the RHPN result is more difficult because human RHPN1 as well as 
human RHPN2 had a repressive effect and mouse RHPN1 had not. It has to be noted, 
that mRHPN1 should be tested in murine cells since it may be nonfunctional in our 
experimental background. Nevertheless, microscopic analysis of these infection 
assays revealed a further, unique, effect of human RHPN1. 
Transfections of human RHPN1 resulted in rod shaped accumulations of our protein 
in the GFP channel, reminiscent of bacteria (Figure 40) accumulating the GFP tagged 
protein. Gentamycin protection assay (Figure 42) however revealed no increased 
numbers of living intracellular bacteria. Given the connection between RHPN1 and 
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autophagy, we analyzed if these green bacteria maybe dead and intracellular, by 
using inside out staining. These assays revealed co-localizations with extra and 
intracellular LPS positive spots. From the result we can conclude that we are indeed 
looking at active autophagy. The localization is a clear hint that human RHPN1 
participates in EPEC infection (Figure 43). Since we could not observe any protein 
accumulations in the first 60 min post infection, human RHPN1 seems to take part 
only in later stages of the infection. It will be interesting to follow this trail to learn 
more about the highly regulated mechanisms behind an EPEC infection, especially 
with respect to the exact role of RHPN1 during this process. 
 
3.6 Collaborative projects 
During the accruement of this thesis, I participated in two collaborative projects, with 
our cooperation partners on related topics.  
The first one was the characterization of a stable, viable mouse fibroblast cell line, 
genetically depleted for Rac1 (Steffen et al., 2013). Those cells, also lacking any 
detectable Rac2 and Rac3 activity, were deficient in the formation of lamellipodia 
and strongly affected in migration. This was shown in 2D wound healing assays and 
chemotaxis assays. The formation of filopodia, spreading and of focal complex 
assembly were assessed. Cell spreading was accomplished by filopodia formation 
and subsequent flow of membrane and cytoplasm in the space between them. 
Because earlier attempts to generate a viable genetic knock out cell line failed, it was 
thought that Rac1 participates essentially in cell proliferation (Vidali et al., 2006, 
Guo et al., 2006). Our cells show that this link is not essential but can be bypassed. 
Yet, in large parts we could confirm the current knowledge. I am sure, that with this 
new viable Rac1 knock out cell line, we got a strong tool to gain deeper insides into 
the broad functions of the important Rac1 GTPase. For infection research, it will be 
interesting to revisit the role of Rac for bacterial pathogenesis. Also in the case of 
EPEC and given the strong interaction of RHPN1 with CA Rac1, analyses with the 
help of these cells will be very interesting.  
Within the framework of this project, I was involved in the detection of Rac2 and 
Rac3 levels. Furthermore I contributed in the analysis of the focal contact formation. 
Finally the effect of bacterial Rac1 GEFs (IpgB1) in these cells was tested.  
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The second collaborative project was in cooperation with Sonja Blasche from the 
DKFZ in Heidelberg. It was about the identification of novel targets of EHEC 
effector proteins with focus on Tir. Based on a Y2H screen, six novel and two 
already published EPEC-Tir interactors were identified and subsequently confirmed. 
It was my part to test the new interactors in infection assays and to perform 
immunofluorescence microscopy for their recruitment to the infection site. Beside 
the positive controls BAIAP1 and -2, which were strongly recruited, we observed the 
serin/threonine kinase 16 (STK16) and hippocalcin-like1 (HPCAL1) to be targeted 
towards the infection side. In this case STK16 is interesting, because it is known that 
Tir has to be phosphorylated before actin reorganization and pedestal formation is 
started (Campellone, 2010). These results will be submitted in due time (Blasche et 
al., in prep.) 
 
3.7 Concluding remarks 
This work provides new insides into host pathogen interaction on the protein level. 
We discovered human RHPN1 as a novel target of the A/E group virulence factor 
Map. Furthermore we showed considerable evidences that the Shigella effector 
IpgB2 is able to interact with the human protein BBS4 and finally the Salmonella 
virulence factor SifA was shown to bind the small GTPase Rab9 in pull down assays. 
Based on a Y2H screening, the poorly defined RhoA-interactor RHPN1 and the 
translocated virulence factor Map, with the ability to provoke cytoskeletal 
reorganizations, were found to interact with each other. By utilizing biochemical and 
microscopic techniques we were able to confirm this finding. Although the 
interaction is verified, its biological function still remains elusive and needs further 
studies. To get a better impression of cellular localization of the RHPN1 Map 
interaction, it will be instrumental to use confocal video microscopy. Also a 
co-staining with markers for different vesicle populations should be considered, to 
see if there are compartments, other than mitochondria, where the interaction takes 
place. An infection assay using a ΔMap EPEC mutant will uncover if the observe 
RHPN1 recruitment is indeed Map dependent. In vise versa experiment with RHPN1 
knock down cells we will reveal defects in establishment of the infection. In case 
RHPN1 is involved in the defense mechanism of autophagy, infection may even be 
enhanced when RHPN1 is absent. 
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BBS4 is known to be involved in the formation of the primary cilium and in the 
recycling of different receptors on its surface. Since the cilium is almost ubiquitous 
in eukaryotic cells, it is imaginable that this compartment is a target of virulence 
factors. There is nothing known about any interference of pathogens with pathways 
like hedgehog or wnt, whose receptors are organized by BBS4, but it might be an 
interesting topic of further studies. However, for the case that centriolar satellites are 
sites of cell cycle control (Staples et al., 2012, Kim et al., 2004) it can be speculated 
that Shigella targets BBS4 to affect the host´s cell division cycle. This has been 
shown before (Iwai et al., 2007). 
The interaction between SifA and Rab9 was only shown in one directional pull down 
assays. So it is mandatory to spend more effort to verify this interaction. However, 
both proteins were reported to be involved in the formation and maintenance of Sifs. 
This circumstance makes an interaction plausible. Nevertheless, at least 
co-localization studies should be performed to confirm a relation between both 
proteins in time and space.  
Even if the insights reported here, are just small pieces of a huge puzzle, they may 
contribute to the growing pool of knowledge on infectious diseases.  
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4 Material  
4.1 Chemicals 
If not further mentioned, all chemicals used in this thesis, were purchased from 
AppliChem, Fermentas, Invitrogen, Machery-Nagel, Merck, Millipore, New England 
Biolabs, Quiagen, Roche, Roth, Sigma-Aldrich, Thermo Fischer Scientific and not 
listed in detail. Water used in this study was purified and distilled with a Milli-Q 
Advantage A10 System (Merck Millipore Billerica). If not further specified, 
solutions were prepared in H2Odd. 
4.2 Cell culture reagents and plasticware 
Cell culture media and supplements were purchased, if not further mentioned from 
Gibco, PAA and Sigma-Aldrich. Plasticware was ordered from Greiner, Sarstedt, 
Techno Plastic Products and Thermo Fischer Scientific. 
4.3 Bacterial strains 
The following bacterial strains were used in this study. 
Table 2 List of bacterial strains used in this study 
Bacterial strain Function Source 
Escherichia coli TG2 cloning Stratagene 
Escherichia coli DH5α cloning Invitrogen 
Escherichia coli DB3.1 gateway cloning Invitrogen 
Escherichia coli BL21 protein expression Invitrogen 
Escherichia coli C600 infection assays Stratagene 
EPEC E2348/69 infection assays Iguchy A. 2009 
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4.4 Cell lines 
The following cell lines were used in this study. For medium (see 5.2.1) 
Table 3 List of mammalian cell lines used in this study 
Cell line Organism Type Function Medium 
B16-F1 Mm melanoma, skin protein expression 1 
Hela Hs cervical cancer microscopy 2 
Cos7 C. aethiops kidney  microscopy, infection assays 3 
4.5 Plasmids 
Plasmids used in this study are listed below (intermediate clones not shown)  
Table 4 List of plasmids used in this study 
Plasmid Number Function Source 
pGBT9-GW SAR 17 intermediate vector Y2H DKFZ 
pDONR-211 SAR 18 final vector Y2H Invitrogen 
pEGFP C1 SAR 34 GFP-tagged expression vector Clontech 
pEGFP C1-RhoG V12 SAR 35  this group 
pEGFP C1-IpgB1 SAR 36  this group 
pDONR211-GW-IpgB1-W76A SAR 37 final clone for Y2H this study 
pDONR211-GW-IpgB2-ΔmemB-W62A SAR 38 final clone for Y2H this study 
pDONR211-GW-IpgB2-W62A SAR 39 final clone for Y2H this study 
pDONR211-GW-IpgB2-ΔmemB SAR 40 final clone for Y2H this study 
pDONR211-GW-SifB-Δext 99-336 SAR 41 final clone for Y2H this study 
pDONR211-GW-EspM2-Citero SAR 42 final clone for Y2H this study 
pDONR211-GW-IpgB1 SAR 43 final clone for Y2H this study 
pDONR211-GW-EspT-EPEC SAR 44 final clone for Y2H this study 
pDONR211-GW-Map SAR 45 final clone for Y2H this study 
pDONR211-GW-SifA-FL SAR 46 final clone for Y2H this study 
pDONR211-GW-IpgB1-ΔmemB SAR 47 final clone for Y2H this study 
pDONR211-GW-SifA-Δext SAR 48 final clone for Y2H this study 
pDONR211-GW-EspT-Citero SAR 49 final clone for Y2H this study 
pDONR211-GW-IpgB1-ΔmemB-W76A SAR 50 final clone for Y2H this study 
pDONR211-GW-IpgB2 SAR 51 final clone for Y2H this study 
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pRK5-Rac1 L61-Myc SAR 54 pull down; microscopy this group 
pcDNA3-RhoGV12-3Myc SAR 55 pull down; microscopy this group 
pDONR211-GW-SopE SAR 68 final clone for Y2H this study 
pDONR211-GW-SopE FL SAR 69 final clone for Y2H this study 
pDONR211-GW-SopE2 SAR 70 final clone for Y2H this study 
pDONR211-GW-SopE2 FL SAR 71 final clone for Y2H this study 
pDONR211-GW-SopB FL SAR 72 final clone for Y2H this study 
pDONR211-GW-SopB N 1-351 SAR 73 final clone for Y2H this study 
pDONR211-GW-SopB C 352-562 SAR 74 final clone for Y2H this study 
pDONR211-GW-IpGD SAR 75 final clone for Y2H this study 
pDONR211-GW-IpGB1 H136A SAR 76 final clone for Y2H this study 
pDONR211-GW-IpGB2 H121A SAR 77 final clone for Y2H this study 
pEGFP-C2-Arf6Q67L SAR 88 pull down; microscopy this group 
pGEX-6P-1 SAR 90 protein expression vector Amersham 
pGEX-6P-3 SAR 91 protein expression vector Amersham 
pEGFP-C1-Rac Q61L SAR 92 pull down; microscopy this study 
pEGFP-C2 SAR 96 GFP-tagged expression vector Clontech 
pEGFP-C3 SAR 97 GFP-tagged expression vector Clontech 
pEGFP-C1-SifB-Δext 99-336 SAR 98 pull down; microscopy this study 
pEGFP-C1-EspT-EPEC SAR 99 pull down; microscopy this study 
pEGFP-C1-Map SAR 100 pull down; microscopy this study 
pEGFP-C1-SifA-FL SAR 101 pull down; microscopy this study 
pEGFP-C1-SifA-Δext SAR 102 pull down; microscopy this study 
pEGFP-C1-EspT-Citero SAR 103 pull down; microscopy this study 
pEGFP-C1-SopB FL SAR 104 pull down; microscopy this study 
pEGFP-C1-SopB N 1-351 SAR 105 pull down; microscopy this study 
pEGFP-C1-SopB C 352-562 SAR 106 pull down; microscopy this study 
pEGFP-C1-IpGD SAR 107 pull down; microscopy this study 
pEGFP-C1-hum RHPN1 SAR 108 pull down; microscopy this study 
pEGFP-C3-hum RHPN2 SAR 109 pull down; microscopy this study 
pGEX-6P-3-hum RHPN1 SAR 111 protein expression this study 
pGEX-6P-1-hum RHPN2 SAR 112 protein expression this study 
pGEX-6P-1-EspT-EPEC SAR 114 protein expression this study 
pGEX-6P-1-EspT-Citero SAR 115 protein expression this study 
pJET1.2 SAR 116 cloning vector Fermentas 
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pQE-30 SAR 117 protein expression vector Qiagen 
pQE-30-SifB-Δext 99-336 SAR 118 protein expression this study 
pQE-30-SifA-FL SAR 119 protein expression this study 
pQE-30-SifA-d ext SAR 120 protein expression this study 
pEGFP-N1-Arf6-WT SAR 121 pull down; microscopy P. Chavrier 
pEGFP-N1-Arf6-T44N SAR 122 pull down; microscopy P. Chavrier 
pEGFP-N1-Arf6-Q67L SAR 123 pull down; microscopy P. Chavrier 
pEGFP-N1-Arf6-T157N SAR 124 pull down; microscopy P. Chavrier 
pEGFP-N1-Arf6-T27N SAR 125 pull down; microscopy P. Chavrier 
pGEX-6P-1-SifB-Δext 99-336 SAR 129 protein expression this study 
pGEX-6P-1-Map SAR 130 protein expression this study 
pGEX-6P-1-SifA FL SAR 131 protein expression this study 
pGEX-6P-1-SifA-Δext SAR 132 protein expression this study 
pGEX-6P-1-SopB-FL SAR 133 protein expression this study 
pGEX-6P-1-SopB N 1-351 SAR 134 protein expression this study 
pGEX-6P-1-SopB C 352-562 SAR 135 protein expression this study 
pGEX-6P-1-IpgD SAR 136 protein expression this study 
pRK5-Cdc42-WT-myc (iso1) SAR 137 pull down; microscopy this group 
pRK5-Rac1-WT-myc (iso1b) SAR 138 pull down; microscopy this group 
pEGFP-C1-IpgB1-W76A SAR 139 pull down; microscopy this study 
pEGFP-C1-IpgB2-ΔmemB-W62A SAR 140 pull down; microscopy this study 
pEGFP-C1-IpgB2-W62A SAR 141 pull down; microscopy this study 
pEGFP-C1-IpgB2-ΔmemB SAR 142 pull down; microscopy this study 
pEGFP-C1-EspM2-Citero SAR 143 pull down; microscopy this study 
pEGFP-C1-IpgB1 SAR 144 pull down; microscopy this study 
pEGFP-C1-IpgB1-ΔmemB SAR 145 pull down; microscopy this study 
pEGFP-C1-IpgB1-ΔmemB-W76A SAR 146 pull down; microscopy this study 
pEGFP-C1-IpgB2 SAR 147 pull down; microscopy this study 
pEGFP-C1-SopE catalytic domain SAR 148 pull down; microscopy this study 
pEGFP-C1-SopE FL SAR 149 pull down; microscopy this study 
pEGFP-C1-SopE2 catalytic domain SAR 150 pull down; microscopy this study 
pEGFP-C1-SopE2 FL SAR 151 pull down; microscopy this study 
pEGFP-C1-IpGB1 H136A SAR 152 pull down; microscopy this study 
pEGFP-C1-IpGB2 H121A SAR 153 pull down; microscopy this study 
pETM-41-IpgB2 SAR 161 protein expression Sally (BS) 
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pETM-41-EspT (EHEC) SAR 162 protein expression this group 
pETM-41-EspT (Citero) SAR 163 protein expression this group 
pETM-41-Map SAR 164 protein expression this group 
pETM-41 SAR 165 protein expression vector EMBL 
pRK5-Cdc42-Q61L-myc SAR 166 pull down; microscopy L. Machesky 
pRK5-Cdc42-T17N-myc SAR 167 pull down; microscopy L. Machesky 
pRK5-Rac1-Q61L-myc SAR 168 pull down; microscopy L. Machesky 
pRK5-Rac1-T17N-myc SAR 169 pull down; microscopy L. Machesky 
pRK5-RhoA-G14V-myc SAR 170 pull down; microscopy L. Machesky 
pRK5-RhoA-T19N-myc SAR 171 pull down; microscopy L. Machesky 
pEGFP-C1-hum RHPN1 Bro SAR 172 pull down; microscopy this study 
pEGFP-C1-hum RHPN1 HR1 SAR 173 pull down; microscopy this study 
pEGFP-C1-hum RHPN1 PDZ SAR 174 pull down; microscopy this study 
pEGFP-C1-ATP6V1E1 SAR 176 pull down; microscopy this study 
pETM-41-SifB Δext SAR 178 protein expression this group 
pETM-41-SifA Δext SAR 179 protein expression this group 
pmCherry-C1 SAR 180 RFP-tagged expression vector Clontech 
pmCherry-C1-Map SAR 181 pull down; microscopy this study 
pGEX-2T-RhoA WT SAR 182 protein expression this group 
pDONR211-GW-SseJ SAR 184 final clone for Y2H this study 
pETM41-IpgB1 SAR 189 protein expression this group 
pETM41-SopB SAR 190 protein expression this group 
pETM41-RhoAT17N SAR 192 protein expression this group 
pEGFP-C1-humRHPN2-PDZ SAR 193 pull down; microscopy this study 
pEGFP-C2-mRhoG wt SAR 202 pull down; microscopy this group 
pEGFP-C1-hRhoG G12V SAR 203 pull down; microscopy this group 
pEGFP-C1-hRhoG T17N SAR 204 pull down; microscopy this group 
pEGFP-C1-RADIL-PDZ SAR 209 pull down; microscopy this study 
pEGFP-C1-mus RHPN1-PDZ SAR 210 pull down; microscopy this study 
pEGFP-C1-mus RHPN2-PDZ SAR 211 pull down; microscopy this study 
pRK5-myc(new)-Map SAR 215 pull down; microscopy this study 
pRK5-myc(new)-SifA SAR 216 pull down; microscopy this study 
pRK5-myc(new)-EspT Citero SAR 217 pull down; microscopy this study 
pRK5-myc(new)-IpgB2 SAR 218 pull down; microscopy this study 
pEGFP-C1-mus RHPN1 SAR 220 pull down; microscopy this study 
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4.6 Oligonucleotides 
Plasmids were generated using oligonucleotides listed below. Oligonucleotides were 
purchased from Eurofins MWG GmbH. 
Table 5 List of oligonucleotides used in this study 
Designation Sequence 5’ - 3’ 
Generation of GFP or GST tagged human RHPN1 
SAR-P3 AAGGATCCATGATCTTAGAGGAGAGGCCGG 
SAR-P4 TTGAATTCTCATGGCCATCCTGGGTGCT 
Generation of GFP or GST tagged human RHPN2 
SAR-P7 AACTCGAGATGACTGACGCACTGTTG 
SAR-P8 TTCTCGAGTTAGTACCAAGAGCTGTCTGAG 
Generation of GFP or GST tagged mouse RHPN1 
SAR-P5 ATGGATCCATGATACTTGAGGAGAGGCC 
SAR-P34 TTGAATTCTCATCCTCGTGCTCGTGCT 
Inverse PCR to delete an intron from mouse RHPN1 
SAR-P37 TCCGCTGGCCTGAAGGAGGG 
SAR-P38 CTCAGCCTGACCCCCTGGAA 
Site directed mutagenesis to solve a point mutation in mouse RHPN1 
SAR-P39 GGCTGAGTCCGCTGGCCTGAAGGAGGGCGACTACATCGTG 
SAR-P40 CCAGCGGACTCAGCCTGACCCCCTGGGACGACAGCAGCGA 
Generation of GFP tagged human RHPN1 BRO domain 
SAR-P11 ATGCAGGATCCATGGTCACTGTCCCTATGATCCC 
SAR-P12 TGCATGTCGACACGCCACCGGTTCTTAGC 
Generation of GFP tagged human RHPN1 HR1 domain 
SAR-P13 ATGCAGGATCCATGGGCTGTGACTCTCTGACGC 
SAR-P14 TGCTTGTCGACATGCCGGCCAGGGTCC 
Generation of GFP tagged human RHPN1 PDZ domain 
SAR-P15 ATCGAGGATCCATGGTGGGGCCCGTGCATCTG 
SAR-P16 TGCATGTCGACCCGCCTCTCCCGCAGC 
Generation of GFP tagged human RHPN2 PDZ domain 
SAR-P25 ATCCAAGATCTATGCCTCGAAGTATCCGCTT 
SAR-P26 TGCATGTCGACCACAACTTTCATCTCGATC 
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Generation of His-MBP tagged human RHPN2 PDZ domain 
SAR-P31 GTGCACCATGGTGCCTCGAAGTATCCGCTT 
SAR-P32 TGCATGCGGCCGCCACAACTTTCATCTCGATC 
  
4.7 Antibodies 
The antibodies, antisera and fluorescent dyes used in this study are listed below. 
Abbreviations in this table: mouse (m), rabbit (r), goat (g), monoclonal (mc), 
polyclonal (pc), western blot (WB), immunoprecipitation (IP) and 
immunofluorescence microscopy (IF). 
Table 6 List of antibodies and fluorescent dyes used in this study 
Designation Source Application Reference 
primary antibodies 
α-CHMP4B r/pc WB (1:1000); IF (1:100) Abcam 
α-CHMP4B r/pc WB (1:1000); IF (1:100) Santa Cruz 
α-Myc m/mc WB (1:1); IF (1:1) Supernatent, hybridoma clone 9E10 
α-E.coli J5 LPS r/pc IF (1:200) Novus Biologicals 
α-GFP m/mc WB (1:1000) Purified, hybridoma clone 101G4B2 
α-mouse-HRP g/IgG/M WB (1:2000) Jackson Immunoresearch Laboratories 
α-rabbit-HRP g/IgG WB (1:2000) Jackson Immunoresearch Laboratories 
secondary antibodies 
α-mouse-Alexa 594 g/IgG IF (1:200) Jackson Immunoresearch Laboratories 
α-rabbit-Alexa 594 g/IgG IF (1:200) Jackson Immunoresearch Laboratories 
α-mouse-Alexa 350 g/IgG IF (1:50) Jackson Immunoresearch Laboratories 
α-rabbit-Alexa 350 g/IgG IF (1:50) Jackson Immunoresearch Laboratories 
fluorescent dyes  
phalloidin-Alexa 594 - IF (1:100) Invitrogen 
phalloidin-Alexa 350 - IF (1:50) Invitrogen 
DAPI - IF (1:50) Invitrogen 
MitoTracker Red - IF (500 nM) Invitrogen 
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4.8 Kits  
Kits used in this study are listed below 
Table 7 List of kits used in this study 
Designation Application Source 
NucleoSpin
®
 Extract II DNA fragment purification Macherey-Nagel 
NucleoBond
®
 PC100 plasmid purification Macherey-Nagel 
GeneJET Plasmid Mini plasmid purification Thermo FischerScientific 
Anti-c-Myc Immunoprecipitation immunoprecipitation Sigma-Aldrich 
Gatway
®
 Cloning DNA cloning Invitrogen 
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5 Methods 
5.1 Cultivation of bacteria 
Bacterial strains were grown in appropriate volume of Luria Bertani broth (LB) 
medium at 37°C with aeration on a rotating shaking platform. If required, antibiotics 
were added to LB broth at the respective concentration (kanamycin (kana) 50 μg/ml; 
ampicillin (amp) 100 μg/ml; chloramphenicol (ch) 34 μg/ml in ethanol). 
 
5.1.1 Preparation of RbCl competent bacteria 
In the morning an E.coli pre culture was diluted 1:100 into 300 ml LB medium 
containing 300 µl of 1 M MgCl2. The suspension was incubated on a shaker at 37°C 
for 2-3 h (until OD600 =0.4-0.6). Next the bacteria were pelleted for 5 min by 4500 xg 
at 4°C and resuspended in 120 ml ice cold TFB1 (do not vortex), followed by a 
5 min incubation on ice. Then bacteria were pelleted again for 5 min by 4500 xg at 
4°C and resuspended in 6-12 ml ice cold TFB2, according to the pellet size (do not 
vortex). After a final incubation of 15-60 min on ice, bacteria were aliquoted in 
30-50 µl, shock frosted in liquid N2 and stored at -80°C. 
 
TFB1   TBF2 
30 mM KAc 
set pH 5.8 by  
using HAc 
sterilize buffer  
by filtration 
  10 mM PIPES 
set pH 6.5 by  
using 1 M KOH 
sterilize buffer  
by filtration 
10 mM CaCl2   75 mM CaCl2 (2H2O) 
50 mM MnCl2   10 mM RbCl 
100 mM RbCl   15 % Glycerol 
15 % Glycerol    
 
5.1.2 Transformation of chemical competent E.coli 
To transform bacteria with plasmid DNA, an aliquot of competent bacteria was 
defrosted on ice. Next, the DNA solution was given to the bacteria in a ratio of 
1:100-1:10 and mixed carefully. Now the mixture was incubated 30-60 minutes on 
ice, followed by a 1 min heat shock at 42°C and a regeneration step with 1 ml LB at 
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37°C on a shaker for 30-60 minutes. Finally the bacteria were pelleted, resuspended 
in 100 µl LB and spreaded on LB-agar which contain the appropriate antibiotics.  
5.2 Cell culture methods 
5.2.1 Media 
All media were pre warmed to 37°C before use. Sera were heat inactivated at 56°C 
for at least 40 min. After preparing the medium, the solution was sterilized by 
vacuum filtration into a sterile cell culture bottle. 
 
1. B16 DMEM (high gluc) 
 10% FCS (PAA) 
 2 mM Glutamin 
 (+1% PS) 
  
2. Hela MEM (high gluc)  
 10% FCS (Sigma) 
 2 mM Glutamin 
 1% 100mM Natrium-Pyruvat 
 1% 100x neAS 
 (+1% PS) 
  
3. Cos7 DMEM (high gluc) 
 10% FCS (Sigma) 
 (+1% PS) 
 
5.2.2 Cultivation 
Cells were splited every two or three days if the cells covered 90-95% of the dish. In 
order to split cells, the old medium was removed completely, including 1x washing 
with PBS. Afterwards an incubation step with an appropriate amount of trypsin 
(PAA) in the cell culture incubator, to detach the cells from the surface, followed. 
Now the cell suspension was diluted in fresh growth medium. In case of B16 cells 
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this diluted cell suspension was directly seeded into a new medium containing tissue 
culture treated dish (1:10 and 1:20). In case of Hela and Cos7 cells the solution was 
centrifuged 4 min by 1000 xg at RT. Then the pellet was resuspended in fresh media 
to get rid of all trypsin. Next, those cells were also given into new medium 
containing dishes (1:3-1:10). For growth, cells were placed into the humid incubator 
at 37°C with 5 % CO2. 
 
5.2.3 Freezing and thawing of cells  
For long time storage, 3 confluent 10 cm dishes were treated with trypsin and 
centrifuged as it was described in the previous paragraph. Cells were resuspended in 
10 ml 4°C cold growth medium containing 10 % dimethylsulfoxide (DMSO, Sigma) 
and aliquoted in 1 ml into cryotubes, which where than placed, overnight, into an 
isopropanol filled Mr. Freeze box (Nalgene) at -80°C. On the next day, the cells were 
transferred for long time storage into liquid nitrogen. 
To thaw cells, a tube was taken from the liquid nitrogen and unfreezed at 37°C in a 
water bath. Then the cell suspension was transferred into a 15 ml falcon and stepwise 
diluted in 10 ml fresh growth medium. After that, cells were pelleted, resuspended in 
fresh medium and seeded into a 10 cm dish. 
 
5.2.4 Transfection of mammalian cells 
24 h prior to transfection, the cells were seeded at a higher concentration (1:10 for 
B16 and 1:3 for Hela and Cos7). At the day of transfection a mixture of pure DNA 
(ideal concentration around 1 µg/µl) and an appropriate transfection reagent was 
according to the manufacturer manual made. In case double transfections the amount 
of each plasmid was reduced by 30 % compared to the single approach. Transfection 
of B16 was performed with SuperFect
®
 (Quiagen), while Hela and Cos7 cells were 
transfected with X-tremeGene
®
HP and X-tremeGene
®
9 (both Roche) respectively. 
After 60 minutes incubation, the solution was applied to the cells. Depending on 
DNA and reagents toxicity, the cells were incubated with the DNA/transfection 
reagent solution for 6 to 16 h in order to allow DNA uptake and protein expression. 
In some cases of severe toxicity, a rescue by medium exchange after 2 h was 
necessary.  
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5.2.5 Cell preparation for fluorescence microscopy 
Hela or Cos7 cells were splited at the evening before transfection in a 1:3 or 1:5 ratio 
respectively and normally and usually seeded into a 3 cm dish. The next morning, the 
transfection was made and incubated for 12 to 24 h. After incubation, the cells were 
again splited (1:1 or 1:2) on pre washed glass coverslips coated with Fibronectin 
(Roche) (1:40 dilution in PBS incubated for 1 h, then 3 times washed with PBS). 
Coverslips were usually used with 12 well plates. Within 6 to 12 h cells attach to the 
glass, spread and were ready for fixation. 
 
5.2.6 Infection assay 
The assay was performed as previously described by Lommel (Lommel et al., 2004). 
Two days before the assay started, Cos7 cells were transfected in a 3 cm dish with 
the DNA of interest. One day later, the transfected cells were seeded 1:3 on 
Fibronectin coated coverslips in a 12-well plate, using medium without any 
antibiotics. Furthermore a LB pre culture of EPEC and E.coli C600 as a negative 
control was started. In the morning of the day of the infection assay, 0.5 ml of the 
overnight pre cultures were pelleted by 4000 xg and two times washed with 1 ml of 
DMEM. Now the bacteria were resuspended in 25 ml of DMEM and incubated on a 
shaker at 37°C. Three hours later, the medium was taken off the Cos7 cells and 
replaced by 1.5 ml of a 1:75 DMEM dilution of the bacteria. Now the cells were 
placed into an incubator under normal cell culture conditions. After 10, 30, 60 and 
180 min cells were fixed by replacing the bacteria solution with pre warmed PBS 
containing 4 % of PFA for 30 minutes. After fixation, cells were prepared for 
microscopy (see 5.5). In case of incubation of cells with bacteria longer than 1 h, the 
medium had to be changed every 60 min in order to prevent bacterial overgrowth.  
 
5.2.7 Gentamicin protection assay 
One day before the assay Cos7 cells were seeded 1:2 in 24-well plate using medium 
without antibiotics. Furthermore a LB pre culture of EPEC and E.coli C600 as a 
negative control was started. In the morning of the day of the gentamicin protection 
assay, 0.5 ml of the overnight pre cultures were pelleted by 4000 xg and two times 
washed with 1 ml of DMEM. Now the bacteria were resuspended in 16.5 ml of 
DMEM and incubated on a shaker at 37°C. Three hours later, the medium on the 
Material 92 
 
Cos7 cells was replaced by a 1:100 DMEM dilution of the bacteria, followed by a 3 h 
incubation under normal cell culture conditions. To prevent bacterial overgrowth, the 
medium was changed every 60 minutes. After 3 h the cells were washed twice with 
pre warmed PBS, followed by another 90 min incubation in 1.5 ml medium 
containing 50 µg/ml gentamicin. After all extracellular bacteria were killed, cells 
were washed twice with PBS, then incubated for 5 min with 1 ml 0.2 % 
Triton-X-100 in H2O. The lysates were collected. Finally every lysate was diluted 
1:10, 1:100 and 1:1000 in PBS. 100 µl of each dilution were plated on LB-agar 
plates without antibiotics and incubated overnight at 37°C. On the next day, the 
colonies of at least two dilutions were counted. The experiment was performed in 
triplicates, data processed with Microsoft Excel 2010. 
5.3 Molecular biological methods 
5.3.1 Yeast two hybrid screen 
The Y2H screen was performed and the data evaluated by Manfred Kögl and Frank 
Schwarz from the Genomics and Proteomics Core Facilities at the German Cancer 
Research Center in Heidelberg as described in 2007 (Koegl et al., 2007) 
 
5.3.2 Polymerase chain reaction (PCR) 
For PCR reactions, Phusion High Fidelity DNA Polymerase (Thermo Fisher) with 
proof-reading activity was used. Constructs were designed using ApE (Version 
2.0.44, University of Utah). Primer annealing temperatures and secondary structures 
were analyzed with the OligoAnalyzer
®
 web tool from the IDT homepage. 
 
Standard PCR approach: 
1 x  HF Phusion buffer  
2 pmol  dNTP  
2.5 pmol  primer I and II  
1 pg  template DNA  
1 U  Phusion DNA polymerase  
ad. 50 μl  H2Odd  
 
Material 93 
 
Standard PCR program: 
98°C 30 s 
98°C 10 s 
55-72°C 15 s 
72°C 30 s/1000 bp 
72°C 10 min 
4°C ∞ 
 
5.3.3 Inverse PCR 
The inverse PCR was performed like the standard PCR described in the paragraph 
before, only with primer directed into opposite directions and less polymerization 
cycles (12-15). Right after the PCR, the DNA was treated with 5 U DpnI for 2 h at 
37°C to get rid of the template DNA. The next step was a gel electrophoresis, 
followed by DNA gel extraction (see 5.3.5). Finally a self-ligation was performed, 
before the transformation.  
 
5.3.4 Site directed mutagenesis 
The site directed mutagenesis was performed as described previous by Liu (Liu et 
al., 2008). 
 
5.3.5 DNA gel electrophoresis and gel extraction  
After PCR or plasmid digestion, the DNA samples were mixed with 5 x loading dye and 
separated by agarose gel electrophoresis at 100 V 45-60 min. The gel consisted of 1-2 % 
low EEO agarose (AppliChem) in 1 x TAE buffer (from 50 x stock, AppliChem) and 
contained 0.5 μg/ml ethidiumbromide. As size marker the GeneRuler 1 kb Plus DNA 
Ladder (Thermo Fisher Scientific) was used. Separated DNA was visualized in an E-Box 
VX2 transilluminator (Peqlab). 
DNA bands were cut out and extracted by the use of the NucleoSpin
®
 Extract II Kit 
(Macherey-Nagel) according to manufacturer’s protocol. 
 
 
 
30 x 
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10 ml 5 x DNA loading dye 
5 ml 30 % Ficoll (as to be autoclaved) 
2 ml 250 mM EDTA pH 8,0 
500 µl 10 % SDS 
200 µl 50 x TAE pH 7,5 
800 µl 0.5 % Xylenblue 
800 µl 0.5 % Bromphenolblue 
700 µl H2O 
 
5.3.6 DNA restriction digest 
Restriction enzymes were purchased from Fermentas/Thermo Fisher Scientific and used 
according to manufacturer’s recommendations. Analytical restrictions were performed in 
a total volume of 20 μl using 1 μg DNA, incubated for 1 h at the recommended 
temperature. Preparative restriction digests were performed in a total volume of 50 μl 
using 2 μg DNA, incubated for 3 h or overnight at the recommended temperature. The 
amount of enzyme used for each digestion was individually calculated according to unit 
definition and number of restriction sites within the respective plasmid. 
 
5.3.7 Ligation of DNA fragments 
Ligation was performed in a total volume of 20 µl using 1 µg vector DNA, 16 µl 
insert DNA and 1 Weiss U T4 DNA ligase (Fermentas/ Thermo Fisher Scientific). 
The ligation mix was incubated at 16°C overnight, inactivated at 65°C for 10 min. 
Finally competent E.coli were transformed with the ligation mix (see 5.1.2). 
 
5.3.8 Gateway cloning 
The procedure was done as described in the Gateway cloning protocol of Invitrogen. 
 
5.3.9 DNA amplification 
E.coli DH5α were transformed (see 5.1.2) with the respective plasmid. On the next 
day bacteria were inoculated into LB medium containing an appropriate antibiotic 
and the cultures were grown overnight at 37°C on a shaker. On the next day, the 
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DNA was extracted by using the NucleoBond PC-100 Kit (Macherey-Nagel) or the 
GeneJet Plasmid Miniprep Kit (Thermo Fisher Scientific) according to the 
manufacturer’s protocol. After cleanup, the plasmid concentration and purity was 
measured with a WPA Biowave S2100 Diode Array Spectrophotometer (Biochrom). 
 
5.3.10 DNA sequencing 
After cloning involving a PCR step, constructs were sequenced. The DNA 
sequencing was performed by Eurofins MWG GmbH. 
5.4 Biochemical methods 
5.4.1 Recombinant protein purification 
The protein expression strain E. coli BL21 was transformed with the expression 
plasmids, which carried the gene for the protein that should be expressed. On the 
next day a 50 ml LB pre culture was inoculated and grown overnight, shaking at 
37°C. The whole suspension was transferred into a baffled flask containing 500 ml 
LB medium supplemented with 2 g/l glucose on the next morning. At an OD600 of 
0.5-0.8, protein expression was induced by adding 0.5 mM IPTG (AppliChem) and 
the culture was grown at 20-37°C for 8-20 h, depending on the respective protein. 
All preparation steps were performed at 4°C to avoid protein degradation and at 
every step of the preparation 50 µl samples were taken for a SDS-PAGE. The cells 
were harvested by 20 min centrifugation at 4,000 xg, the pellet was resuspended in 
10 ml ice cold lysis buffer, a small amount of lysozyme (Roth) was added and then 
the suspension was incubated at 4°C under mixing for 15 min. The cells were opened 
by sonification using an ultrasonic device (UP100H, Hielscher) first time for 1 min, 
followed by 5 x 30 s, between each round of sonification the samples were put on 
ice. The insoluble fraction was removed by 60 min centrifugation at 20,000 xg. 
During centrifugation, 500 μl beads were loaded onto a column, washed twice with 
1 x PBS buffer and once with lysis buffer to equilibrate the beads. The equilibrated 
beads were mixed with the protein-containing supernatant and incubated overnight 
under constant rotation. The next day, the beads were washed four times with 5 ml 
lysis buffer, resuspended in 2 ml resuspension buffer, aliquoted, shock frozen in 
liquid nitrogen and stored at -80°C for long time storage.  
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Successful protein expression, concentration and purity was accessed by mixing each 
sample, taken at each step of the procedure, and 30 μl beads with 10 μl 4 x SDS 
sample buffer and boiled for 5 min at 95°C. Finally 10 μl of these samples were 
loaded on a SDS polyacrylamide gel, 2.5 µl, 5 µl and 10 µl in case of the beads. 
Additionally, three different amounts of bovine serum albumin (BSA), 5, 10 and 
20 μg were loaded on the gel and separated by SDS-PAGE (see 5.4.4). The amount 
of protein bound to the beads was estimated compared to the BSA control.  
 
Buffers for Ni
2+
-NTA beads 
lysis buffer 
50 mM NaH2PO4 
300 mM NaCl 
10 mM Imidazol 
set pH 8.0 using NaOH 
10 mM β-Mercaptoethanol 
 Protease inhibitors cocktail EDTA free 
 Benzonase 
  
washing buffer 
50 mM NaH2PO4 
300 mM NaCl 
10 mM Imidazol 
set pH 8.0 using NaOH 
10 mM β-Mercaptoethanol 
 
Buffers for GST beads 
lysis buffer 
50 mM Tris HCl pH 8.5 
20 % Sucrose 
200 mM N2S 
add always  
fresh 
add always  
fresh 
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2 mM MgCl2 
2 mM DTT 
 Protease inhibitor cocktail EDTA free 
washing buffer 
50 mM Tris HCl pH 7.6 
0.1 % Triton X-100 
150 mM NaCl 
10 mM MgCl2 
 
5.4.2 Pull down analysis  
All steps were performed at 4°C. On the day before the pull down assay, B16 cells 
were transfected with plasmids of interest and incubated overnight under normal cell 
culture conditions (see 5.2.2). The next day in the morning, cells were washed twice 
with PBS and scraped of the dish in 300 µl IP-buffer containing 1 % Triton X-100 
and protease inhibitor cocktail. The lysate was incubated on ice for at least 15 min, 
including several times vortexting. After incubation, the insoluble fraction was 
pelleted by centrifugation at 15,000 xg for 15 min. 30 µl of the supernatant were 
taken and mixed with 4 x SDS-sample buffer as “load control”. 150 µl of the 
supernatant were mixed with 30 µl prey-protein coupled beads and incubated for at 
least 60 min on a rotating wheel in the cool room. Now the beads were pelleted 
(3 min, 500 xg) and washed three times with IP-buffer containing 1 % Triton X-100 
but no protease inhibitor. From the supernatant after the first centrifugation step a 
30 µl sample was taken and mixed with 4 x SDS-sample buffer as “supernatant 
control”. After the last centrifugation step, the beads were resuspended in 30 µl 
4 x SDS-sample buffer “pull down”, boiled for 5 min at 95°C for subsequent 
SDS-PAGE.  
IP-buffer 
15 mM  KCl 
50 mM NaCl 
8 mM Tris, free base 
12 mM Hepes, free base 
add always  
fresh 
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5 mM MgCl2 
1 % Triton X-100 
 Protease inhibitor cocktail EDTA free 
 
5.4.3 Co-immunoprecipitation 
Co-immunoprecipitations of Myc-tagged proteins were performed by using the Anti-
c-Myc Immunoprecipitation Kit (Sigma Aldrich) according to manufacturer’s 
recommendations, or by using 5 µg of GFP antibody. 
 
5.4.4 Protein gel electrophoresis (SDS-PAGE) 
To separate proteins according to their size 9.5 x 6.5 cm, SDS containing 
polyacrylamide gels were used. Gels were poured in customized blocs of 10 to 15 
gels. First the 10 or 15 % separation gels were poured and covered with a layer of 
isopropanol. After 30 min, the gels were polymerized, the isopropanol discarded and 
washed 10 times with water. Then the 5 % stacking gels were poured and the combs 
inserted. Again, after 30 min, polymerization was over and the gels could be 
assembled into customized, SDS-running buffer filed SDS-chambers and loaded with 
SDS-protein samples and pre- or unstained protein ladder (Thermo Fischer 
Scientific). Gels were run at 100 V/gel for 2-3 h 
 
10 x 5 % stacking gel 
23 ml H2O 
10 ml 0.5 M Tris HCl pH 6.8 
6.8 ml 30 % Acrylamid / Bisacrylamid 
400 µl 10 % SDS 
80 µl TEMED 
80 µl 25 % APS 
 
10 x 10 % (15 %) collection gel 
49 (29) ml H2O 
30 (30) ml 1.5 M Tris HCl pH 8.8 
add always  
fresh 
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37 (60) ml 30 % Acrylamid / Bisacrylamid 
1.2 (1.2) ml 10 % SDS 
160 (160) µl TEMED 
160 (160) µl 25 % APS 
 
SDS-running buffer 
25 mM Tris base 
192 mM Glycin 
0.1 % (v/v) SDS 
 
4 x SDS-sample buffer 
25 mM Tris pH 6.8 (HCl) 
29 % (v/v) Glycerol 
3.3 % (v/v) SDS 
3.3 % (v/v) β-Mercaptoethanol 
0.17 % (w/v) Bromphenolblue 
 
5.4.5 Coomassie staining  
To visualize proteins on gels after SDS-PAGE or on PVDF membranes after 
Western blotting, they were shaken in Coomassie staining solution for several hours. 
Excess dye was extracted by shaking the gel or membrane in Coomassie destaining 
solution for 3 h. 
 
Coomassie staining solution 
25 % Methanol 
10 % (v/v) Acetic acid 
0.1 % (w/v) Coomassie Brilliant Blue R250 
 
Coomassie destaining solution 
40 % Methanol 
10 % (v/v) Acetic acid 
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5.4.6 Western blotting and protein detection 
After protein separation by SDS-PAGE, the proteins were transferred from the gel to 
PVDF membranes (Merck-Millipore), using a semi dry blotting system. Prior 
assembling the blotting sandwich in a Semi-dry blotting Biometra Fastblot B44 
(Analytik Jena), filter papers were equilibrated in blotting buffer, the membrane was 
activated in methanol. The blot was run at 150 mA/membrane for 3 h. Blotting 
efficiency was checked by reversible protein staining of the membrane in Ponceau S 
staining solution. 
If the transfer was successful, the membrane was blocked in 10 % milk/TBS-T for 
30 min, incubated with a primary antibody at 4°C overnight on a shaker, followed by 
three 15 min washing steps with TBS-T and another hour shaking incubation with 
the second antibody at room temperature. Finally the membrane was washed again 
three times with TBS-T and once with H2Odd, before the membrane was covered 
with 8 ml LumiLight Western Blotting Substrate (Roche) to detect HRP activity of 
second antibodies in a Geliance 600 Imaging System (Perkin Elmer). 
The resulting image was saved as a TIF-file and processed in Adobe
®
 Photoshop 
CS6 Extended (Adobe Systems). 
 
Ponceau S solution 
5 g Ponceau S 
0.4 % (v/v) Methanol 
15 % (v/v) Acetic acid 
 
Blotting buffer 
50 mM Tris base 
38.5 mM Glycine 
1.3 mM SDS 
20 % (v/v) Methanol 
 
TBS (-T) 
200 mM Tris base 
1.37 M NaCl 
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pH 7.6 (HCl) 
(0.1 % (v/v) Tween 20) 
  
5.4.7 Stripping of PVDF membranes 
In order to remove antibodies from PVDF membranes, they were 5 min shaken in 
buffer A at room temperature and subsequent 10 min in buffer B, followed by two 
washing steps in TBS-T. After blocking, the membrane was ready for another 
antibody. 
 
Stripping buffer A 
500 mM NaCl 
200 mM Glycine 
pH 2.0 (HCl) 
 
Stripping buffer B 
500 mM Tris base 
pH 11.0 (NaOH) 
 
5.5 Microscopy techniques 
5.5.1 Coverslip washing 
To clarify glass coverslips from production residues, they were shaken for 1 h in 
washing solution at room temperature and washed ten times with H2Odd. After 
sterilization the coverslips were 30 min coated with Fibronectin (25 µg/ml in PBS; 
stock 1 g/l in 2 M urea; Roche) and then washed twice with PBS. 
 
Coverslip washing solution 
60 % (v/v) Ethanol 
40 % (v/v) conc. HCl 
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5.5.2 Staining of mitochondria 
Mitochondria were stained by using 500 nM MitoTracker
®
Red (Invitrogen) 
according to the manufacturer’s manual. 
 
5.5.3 Fixation and immuno-staining of cells 
In order to fixate cells, the medium was quickly replaced by pre warmed 4 % PFA in 
PBS at room temperature. After 20 min cells were permeabilized one minute in 
0.05-1% Triton X-100 (depending on the subsequent antibody staining) in PBS. Then 
the coverslips were three times washed with PBS, followed by a blocking step with 
5 % horse serum (v/v) in PBS containing 1 % BSA (w/v) for 1 h at room temperature 
or overnight at 4°C.  
Subsequently the coverslips were washed several times in PBS and the 
immune-staining was performed by placing a coverslip upside down on a 20 µl drop 
of primary antibody diluted (see 4.7) in PBS containing 1 % BSA. To avoid drying, 
the drop was placed on parafilm in a dark humid chamber. After one hour the 
coverslips were washed again and placed on another drop containing the diluted 
secondary antibody and additional fluorescent dyes. 45 min later the coverslips were 
washed a last time and placed on a 20 µl drop of Mowiol on an ethanol cleaned 
microscope glass slide. The fixation hardened overnight at 4°C. 
 
Mowiol 
0.4 g/ml Mowiol 7200 
1 g/ml Glycerol 
0.2 M Tris pH 9.0 
2.5 % DABCO 
 
5.5.4 Imaging and image processing  
All pictures were taken by using either a PALM IX70 microscope (Olympus) in 
combination with a HXP-120 Light Source (Visitron Systems), a 18.0 Monochrome 
camera w/o IR (Diagnostics Instruments Inc.) and the 60 x objective lens 
UPLFLN60XOI (Olympus) or an Axiovert 200 microscope (Zeiss), equipped with a 
sensicam® qe high performance cooled digital 12bit CCD camera, a pE-2 LED 
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excitation system (CoolLED) light source and the 63 x or 100 x Plan-Neofluar 
(Zeiss). Both microscopes were run with VisiVIEW software (Visitron Systems).  
Images were processed with Adobe
®
 Photoshop CS6 Extended (Adobe Systems) or 
ImageJ 1.43m (National Institute of Health, USA) containing the MBF ImageJ 
plug-in bundle for microscopy (McMaster University, Biophotonics Facility). 
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